<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">GAN</journal-id>
<journal-id journal-id-type="hwp">spgan</journal-id>
<journal-title>Genes &amp; Cancer</journal-title>
<issn pub-type="ppub">1947-6019</issn>
<issn pub-type="epub">1947-6027</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1947601912473477</article-id>
<article-id pub-id-type="publisher-id">10.1177_1947601912473477</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Monographs</subject>
<subj-group subj-group-type="heading">
<subject>From the G2/M Transition to Mitotic Exit</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Decoding Ubiquitin for Mitosis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Fournane</surname><given-names>Sadek</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Krupina</surname><given-names>Ksenia</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Kleiss</surname><given-names>Charlotte</given-names></name>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Sumara</surname><given-names>Izabela</given-names></name>
</contrib>
<aff id="aff1-1947601912473477">Institute of Genetics and Molecular and Cellular Biology (IGBMC), Illkirch, France</aff>
</contrib-group>
<author-notes>
<corresp id="corresp1-1947601912473477">Izabela Sumara, Institute of Genetics and Molecular and Cellular Biology (IGBMC), Illkirch, France (Email: <email>Izabela.Sumara@igbmc.fr</email>).</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>11</month>
<year>2012</year>
</pub-date>
<volume>3</volume>
<issue>11-12</issue>
<fpage>697</fpage>
<lpage>711</lpage>
<permissions>
<copyright-statement>© The Author(s) 2013</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Conjugation of ubiquitin (ubiquitination) to substrate proteins is a widespread modification that ensures fidelity of many cellular processes. During mitosis, different dynamic morphological transitions have to be coordinated in a temporal and spatial manner to allow for precise partitioning of the genetic material into two daughter cells, and ubiquitination of key mitotic factors is believed to provide both directionality and fidelity to this process. While directionality can be achieved by a proteolytic type of ubiquitination signal, the fidelity is often determined by various types of ubiquitin conjugation that does not target substrates for proteolysis by the proteasome. An additional level of complexity is provided by various ubiquitin-interacting proteins that act downstream of the ubiquitinated substrate and can serve as “decoders” for the ubiquitin signal. They may, specifically reverse ubiquitin attachment (deubiquitinating enzymes, DUBs) or, act as a receptor for transfer of the ubiquitinated substrate toward downstream signaling components and/or subcellular compartments (ubiquitin-binding proteins, UBPs). In this review, we aim at summarizing the knowledge and emerging concepts about the role of ubiquitin decoders, DUBs, and UBPs that contribute to faithful regulation of mitotic division.</p>
</abstract>
<kwd-group>
<kwd>mitosis</kwd>
<kwd>ubiquitin</kwd>
<kwd>DUBs</kwd>
<kwd>UBPs</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>November/December 2012</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="section1-1947601912473477">
<title>Conjugating and “Decoding” Ubiquitin</title>
<p>Conjugation of ubiquitin is one of the major posttranslational modifications of proteins in eukaryotic cell. Highly dynamic and reversible, ubiquitination modulates and orchestrates a broad range of cellular processes, including protein degradation, quality control and trafficking, signal transduction, differentiation, and cell division.<sup><xref ref-type="bibr" rid="bibr1-1947601912473477">1</xref><xref ref-type="bibr" rid="bibr2-1947601912473477"/><xref ref-type="bibr" rid="bibr3-1947601912473477"/>-<xref ref-type="bibr" rid="bibr4-1947601912473477">4</xref></sup> In this pathway, ubiquitin is covalently attached to a substrate by coordinated cycles of 3 enzymatic reactions, ubiquitin activation (E1 enzyme), ubiquitin conjugation (E2 enzyme), and ubiquitin ligation (E3 ubiquitin ligase) (<xref ref-type="fig" rid="fig1-1947601912473477">Fig. 1</xref>). One of the mostly described consequences of ubiquitination is degradation of the substrate proteins by a large protease complex, 26S proteasome. Due to its irreversible character, this process provides essential directionality toward various pathways. Importantly, ubiquitination of the targeted substrates does not always serve as a signal for the proteasomal degradation but may also regulate protein localization, binding to other proteins, or even enzymatic activities.<sup><xref ref-type="bibr" rid="bibr5-1947601912473477">5</xref></sup> The covalent linkage of single ubiquitins (mono- ubiquitination or multi-ubiquitination) to the substrates or various modes of ubiquitin binding to the already attached ubiquitin moiety (polyubiquitin chain formation) determine the fate of the substrate protein (<xref ref-type="fig" rid="fig1-1947601912473477">Fig. 1</xref>). A huge variation of the polyubiquitin chains can be formed, as one of the 7 internal lysine residues or the N-terminal methionine can serve as attachment sites in a single ubiquitin molecule. This creates a plethora of possible ubiquitin signals.</p>
<fig id="fig1-1947601912473477" position="float">
<label>Figure 1.</label>
<caption>
<p>Coding and decoding ubiquitin. Coding: Ubiquitin (Ub) is covalently attached to the lysine residues (K) of substrate proteins by a 3-step mechanism involving the sequential actions of E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin ligase) enzymes, resulting in formation of both mono- and multi-ubiquitination signal as well as formation of the poly-ubiquitin chains linked via one of the internal lysine residues or N-terminal methionine residue. The possible physiological outcomes of different ubiquitination signals are indicated in yellow. Decoding: Ubiquitin modifications may be removed by specific de-ubiquitinating enzymes (DUB) and may stabilize substrates or lead to their activation or inactivation (yellow). Ubiquitin-binding proteins (UBP) interact with ubiquitinated proteins and may prevent the conversion of mono-ubiquitin into polyubiquitin chains, protect ubiquitin modifications from DUBs, target proteins to the 26S proteasome, and/or mediate downstream signaling events perhaps through new protein–protein interactions or targeting them to subcellular compartments (yellow).</p>
</caption>
<graphic xlink:href="10.1177_1947601912473477-fig1.tif"/>
</fig>
<p>An additional level of complexity is provided by various ubiquitin-interacting proteins that act downstream of the ubiquitinated substrate and can serve as “decoders” for the ubiquitin signal. They may, specifically reverse ubiquitin attachment (deubiquitinating enzymes, DUBs) or, act as a receptor for transfer of the ubiquitinated substrate toward downstream signaling components and/or subcellular compartments (ubiquitin-binding proteins, UBPs) (<xref ref-type="fig" rid="fig1-1947601912473477">Fig. 1</xref>). Eukaryotic genomes encode for high numbers of both ubiquitin conjugation machinery and “decoders” of ubiquitin signal, constituting a network which by analogy to the signal transduction pathways should ensure a high complexity regulation of cellular processes. It is predicted that human cells express about 600 different E3-ubiquitin ligases, 100 DUBs, and as many as 200 various UPBs. Yet, the precise roles and substrate specificity of these factors are only beginning to be understood. In this review, we aim at summarizing the recently emerging concepts and knowledge about the role of ubiquitin decoders during regulation of mitosis. Excellent existing reviews have described the roles of the E3-ubiquitin ligases known to act during mitotic division,<sup><xref ref-type="bibr" rid="bibr6-1947601912473477">6</xref><xref ref-type="bibr" rid="bibr7-1947601912473477"/>-<xref ref-type="bibr" rid="bibr8-1947601912473477">8</xref></sup> and likewise the role of ubiquitin coding and decoding machinery in regulation of other cell cycle stages has been extensively described.<sup><xref ref-type="bibr" rid="bibr9-1947601912473477">9</xref><xref ref-type="bibr" rid="bibr10-1947601912473477"/><xref ref-type="bibr" rid="bibr11-1947601912473477"/><xref ref-type="bibr" rid="bibr12-1947601912473477"/>-<xref ref-type="bibr" rid="bibr13-1947601912473477">13</xref></sup> Thanks to the high-throughput, whole genome screening efforts in mammalian cells and genetic studies in yeast, we have started to unravel novel mitotic factors that decode versatile ubiquitin signal.</p>
</sec>
<sec id="section2-1947601912473477">
<title>Mitosis</title>
<p>During the mammalian cell cycle, genetic material has to be duplicated and then undergo mitosis, in which the two copies of each chromosome are segregated into two daughter cells (<xref ref-type="fig" rid="fig2-1947601912473477">Fig. 2</xref>). Each of the daughter cells must receive an exact copy of the genetic material, as defects in chromosome segregation can cause genetic instability and aneuploidy, which has been linked to tumorigenesis.<sup><xref ref-type="bibr" rid="bibr14-1947601912473477">14</xref></sup> Thus, for successful mitosis, a precise coordination of the morphological changes with time has to be accomplished. Onset of mitosis is typically marked by the nuclear envelope breakdown and condensation of the replicated DNA during prophase. The individualized chromosomes assemble their kinetochores during prometaphase and metaphase stages. The assembly of the mitotic spindle and its attachment to the sister kinetochores allows proper chromosome segregation. Accurate chromosome segregation requires that sister kinetochores attach to microtubules from opposite spindle poles (bipolar attachment) in metaphase. Kinetochore attachment is a stochastic process and as such is prone to errors, which may result in chromosome misalignment. A complex network of regulatory factors constituting so-called spindle assembly checkpoint (SAC) ensures that sister chromatid segregation in anaphase does not take place before all chromosomes are properly aligned at the metaphase plate and before their kinetochores are under sufficient occupancy and tension by spindle microtubules.<sup><xref ref-type="bibr" rid="bibr15-1947601912473477">15</xref><xref ref-type="bibr" rid="bibr16-1947601912473477"/><xref ref-type="bibr" rid="bibr17-1947601912473477"/>-<xref ref-type="bibr" rid="bibr18-1947601912473477">18</xref></sup> Following successful chromosome segregation, the spindle microtubules undergo a dramatic reorganization, and the anaphase central spindle or spindle midzone is formed. During this transition, the antiparallel, interdigitating microtubules and many associated proteins become organized into discrete bundles in the spindle midzone. Midzone microtubules play an important role in cytokinesis, which separates the cytoplasm of the two daughter cells.<sup><xref ref-type="bibr" rid="bibr19-1947601912473477">19</xref><xref ref-type="bibr" rid="bibr20-1947601912473477"/>-<xref ref-type="bibr" rid="bibr21-1947601912473477">21</xref></sup> Cytokinesis begins with the assembly of a contractile actin-myosin ring. Its contraction results in the formation of the midbody, which is composed of the remnants of the spindle midzone. In the final step, the actomyosin ring disassembles and the plasma membranes resolve in a process called abscission.<sup><xref ref-type="bibr" rid="bibr22-1947601912473477">22</xref></sup> An accepted view is that cytokinesis cannot be completed if chromosomes are pulled apart erroneously or if the anaphase spindle midzone is not formed properly.<sup><xref ref-type="bibr" rid="bibr23-1947601912473477">23</xref></sup> In budding yeast, these defects lead to the activation of the recently described “NoCut” checkpoint pathway.<sup><xref ref-type="bibr" rid="bibr24-1947601912473477">24</xref></sup> In mammalian cells, abscission also fails in such cases, leading to regression of the cleavage furrow and the formation of multinucleated cells.<sup><xref ref-type="bibr" rid="bibr19-1947601912473477">19</xref><xref ref-type="bibr" rid="bibr20-1947601912473477"/>-<xref ref-type="bibr" rid="bibr21-1947601912473477">21</xref></sup></p>
<fig id="fig2-1947601912473477" position="float">
<label>Figure 2.</label>
<caption>
<p>Regulation of mitosis by ubiquitin system. Faithful regulation of mammalian mitotic division (prophase, prometaphase, metaphase, anaphase, and telophase) requires precise coordination of structural transitions. This machinery involves many critical factors and enzymes that need to be precisely regulated in time and space. Thus, both their timely expression and correct localization to the subcellular compartments must be achieved during different morphological transitions. Blue indicates nucleus and chromosomes; green (representing the CPC component, Aurora B) marks the centromere structures during prometa- and metaphases and midzone and midbody regions during anaphase and telophase, respectively; and red marks microtubules and spindle structures. The critical and major ubiquitin E3-ligases (blue) responsible for coding ubiquitin on mitotic factors are depicted. APC/C E3-ligase is a subject of fidelity control by the spindle assembly checkpoint (SAC) network. The ubiquitin decoders, DUBs (green) and UBPs (red), contribute to fidelity and directionality of mitotic division at specific stages and transitions (for details, see text).</p>
</caption>
<graphic xlink:href="10.1177_1947601912473477-fig2.tif"/>
</fig>
<p>Two major E3-ligases are known to control cell division: SCF-complexes regulate the G1 to S-phase transition, and the anaphase-promoting complex/cyclosome (APC/C) coordinates metaphase to anaphase transition and mitotic exit. However, recent findings hint at a more complex picture of regulation of this process, and accumulating evidence suggests a role of SCF ligases in controlling the early mitotic phases.<sup><xref ref-type="bibr" rid="bibr25-1947601912473477">25</xref></sup> Likewise some novel cullin-based E3s, like CUL3, essentially contribute to regulation of mitosis<sup><xref ref-type="bibr" rid="bibr26-1947601912473477">26</xref>,<xref ref-type="bibr" rid="bibr27-1947601912473477">27</xref></sup> (<xref ref-type="fig" rid="fig2-1947601912473477">Fig. 2</xref>).</p>
</sec>
<sec id="section3-1947601912473477">
<title>Role of DUBs During Mitotic Progression</title>
<p>The human genome encodes for about 100 different DUBs, which belong to 5 distinct families. Four of them—USPs (ubiquitin-specific proteases), UCHs (ubiquitin C-terminal hydrolases), OTUs (ovarian tumor), and Josephin family—are cysteine proteases, whereas the fifth DUB family comprises a group of Zn<sup>2+</sup> metalloproteases, which are referred to as JAB1/MPN/MOV34 (or JAMMs).<sup><xref ref-type="bibr" rid="bibr28-1947601912473477">28</xref><xref ref-type="bibr" rid="bibr29-1947601912473477"/>-<xref ref-type="bibr" rid="bibr30-1947601912473477">30</xref></sup> In addition to DUBs acting mostly on substrates modified by ubiquitin, specific enzymes exist that act on other ubiquitin-like molecules (UBLs), but their roles are poorly understood thus far.<sup><xref ref-type="bibr" rid="bibr31-1947601912473477">31</xref></sup> DUBs have been implicated in many physiological and pathophysiological processes, including apoptosis, DNA repair, neuro degenerative diseases, and cancer, but their precise substrates and regulation are known only in some cases. Here, we summarize the DUBs with known functions during the cell division cycle (<xref ref-type="table" rid="table1-1947601912473477">Table 1</xref>) and use examples of DUBs required specifically for mitosis to illustrate complexity of their regulation.</p>
<table-wrap id="table1-1947601912473477" position="float">
<label>Table 1.</label>
<caption>
<p>List of DUBs Regulating Cell Cycle</p>
</caption>
<graphic alternate-form-of="table1-1947601912473477" xlink:href="10.1177_1947601912473477-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Name</th>
<th align="center">Family/<italic>Domains</italic></th>
<th align="center">Cell Cycle Stage</th>
<th align="center">Function</th>
<th align="center">Substrate(s)</th>
<th align="center">References</th>
</tr>
</thead>
<tbody>
<tr>
<td>USP13</td>
<td>USP/<italic>ZnF-UBP, UBA, USP</italic></td>
<td>G1</td>
<td>Together with Ufd1, couples the endoplasmic reticulum stress response to cell cycle control</td>
<td>Skp2</td>
<td><xref ref-type="bibr" rid="bibr129-1947601912473477">129</xref></td>
</tr>
<tr>
<td>BAP1</td>
<td>UCH/<italic>UCH, coiled coil</italic></td>
<td>G1/S</td>
<td>Promotes cell cycle progression by interacting with HCF-1, a transcriptional cofactor for genes required for S phase</td>
<td>HCF-1</td>
<td><xref ref-type="bibr" rid="bibr130-1947601912473477">130</xref></td>
</tr>
<tr>
<td>USP1</td>
<td>USP/<italic>USP</italic></td>
<td>S</td>
<td>Switches off DNA damage pathways, limits the error-prone replication in absence or presence of extrinsic DNA damage</td>
<td>FANCD2-FANCI, PCNA</td>
<td><xref ref-type="bibr" rid="bibr131-1947601912473477">131</xref><xref ref-type="bibr" rid="bibr132-1947601912473477"/><xref ref-type="bibr" rid="bibr133-1947601912473477"/>-<xref ref-type="bibr" rid="bibr134-1947601912473477">134</xref></td>
</tr>
<tr>
<td>USP3</td>
<td>USP/<italic>ZnF-UBP, USP</italic></td>
<td>S</td>
<td>Necessary for proper progression through S phase, involved in DNA damage response and prevents replicative stress</td>
<td>H2A (major substrate), H2B</td>
<td><xref ref-type="bibr" rid="bibr135-1947601912473477">135</xref></td>
</tr>
<tr>
<td>BRCC36</td>
<td>JAMM/<italic>JAMM, coiled coil</italic></td>
<td>DNA damage checkpoint</td>
<td>Allows the turnover of BRCA1-mediated repair in DNA damage response</td>
<td>H2A, H2AX</td>
<td><xref ref-type="bibr" rid="bibr136-1947601912473477">136</xref>, <xref ref-type="bibr" rid="bibr137-1947601912473477">137</xref></td>
</tr>
<tr>
<td>OTUB1</td>
<td>OTU/OTU</td>
<td>DNA damage checkpoint</td>
<td>Noncanonical inhibition of DNA damage response (by blocking ubiquitin transfer)</td>
<td>UBC13 (interacting protein)</td>
<td><xref ref-type="bibr" rid="bibr67-1947601912473477">67</xref>, <xref ref-type="bibr" rid="bibr138-1947601912473477">138</xref></td>
</tr>
<tr>
<td>USP28</td>
<td>USP/<italic>UBA, UIM, USP, coiled coil</italic></td>
<td>DNA damage checkpoint</td>
<td>Regulates the stability of DNA-damage signaling factors, controls stability of c-Myc</td>
<td>Chk2, 53BP1, Claspin, c-Myc</td>
<td><xref ref-type="bibr" rid="bibr139-1947601912473477">139</xref>, <xref ref-type="bibr" rid="bibr140-1947601912473477">140</xref></td>
</tr>
<tr>
<td>USP7</td>
<td>USP/<italic>MATH, USP, UBL</italic></td>
<td>G1/S and G2/M</td>
<td>Regulates the p53-MDM2 pathway</td>
<td>MDM2, p53</td>
<td><xref ref-type="bibr" rid="bibr141-1947601912473477">141</xref>, <xref ref-type="bibr" rid="bibr142-1947601912473477">142</xref></td>
</tr>
<tr>
<td>USP37</td>
<td>USP/<italic>UIM, USP</italic></td>
<td>G1/S, G2/M</td>
<td>Promotes the G1/S transition by inhibiting the APC/C-dependent degradation of Cyclin A, regulation of unknown substrate necessary for the prevention of mitotic entry</td>
<td>Cyclin A, itself, other unknown substrate</td>
<td><xref ref-type="bibr" rid="bibr79-1947601912473477">79</xref>, <xref ref-type="bibr" rid="bibr84-1947601912473477">84</xref></td>
</tr>
<tr>
<td>USP42</td>
<td>USP/<italic>USP</italic></td>
<td>G1/S and G2/M</td>
<td>Necessary for early activation of p53 response</td>
<td>p53</td>
<td><xref ref-type="bibr" rid="bibr143-1947601912473477">143</xref></td>
</tr>
<tr>
<td>USP2a</td>
<td>USP/<italic>USP</italic></td>
<td>G1/S and G2/M</td>
<td>Regulates the p53-MDM2 pathway</td>
<td>MDM2</td>
<td><xref ref-type="bibr" rid="bibr144-1947601912473477">144</xref></td>
</tr>
<tr>
<td>USP50</td>
<td>USP/<italic>USP (predicted to be inactive)</italic></td>
<td>G2/M</td>
<td>Regulates the HSP90-dependent stability of Wee1 (unknown mechanism)</td>
<td>Not known</td>
<td><xref ref-type="bibr" rid="bibr145-1947601912473477">145</xref></td>
</tr>
<tr>
<td>CYLD</td>
<td>USP/<italic>CAP-Gly domains, USP with B-box</italic></td>
<td>M, G1/S</td>
<td>Regulates mitotic entry, assembly of the mitotic spindle, cytokinesis rate after TPA treatment, negatively regulates G1/S progression after TPA treatment</td>
<td>PLK1 (<xref ref-type="table-fn" rid="table-fn2-1947601912473477">?</xref>), Bcl3</td>
<td><xref ref-type="bibr" rid="bibr43-1947601912473477">43</xref>, <xref ref-type="bibr" rid="bibr58-1947601912473477">58</xref>, <xref ref-type="bibr" rid="bibr59-1947601912473477">59</xref></td>
</tr>
<tr>
<td>USP16</td>
<td>USP/<italic>ZnF-UBP, USP</italic></td>
<td>M</td>
<td>Necessary for M phase progression, associated with reversal of DNA silencing after DNA damage response</td>
<td>H2A</td>
<td><xref ref-type="bibr" rid="bibr146-1947601912473477">146</xref>, <xref ref-type="bibr" rid="bibr147-1947601912473477">147</xref></td>
</tr>
<tr>
<td>USP44</td>
<td>USP/<italic>ZnF-UBP, USP</italic></td>
<td>M</td>
<td>Regulation of spindle assembly checkpoint (SAC)</td>
<td>CDC20</td>
<td><xref ref-type="bibr" rid="bibr36-1947601912473477">36</xref>, <xref ref-type="bibr" rid="bibr37-1947601912473477">37</xref></td>
</tr>
<tr>
<td>USP4</td>
<td>USP/<italic>DUSP, UBL, USP</italic></td>
<td>M</td>
<td>Regulation of spindle assembly checkpoint (SAC)</td>
<td>Splicing of a-tubulin and Bub1 mRNA, other mRNAs important for SAC (<xref ref-type="table-fn" rid="table-fn2-1947601912473477">?</xref>)</td>
<td><xref ref-type="bibr" rid="bibr70-1947601912473477">70</xref></td>
</tr>
<tr>
<td>USP39</td>
<td>USP/<italic>ZnF-UBP, USP (inactive)</italic></td>
<td>M</td>
<td>Regulation of spindle assembly checkpoint (SAC)</td>
<td>Splicing of Aurora B mRNA, other mRNAs important for SAC (<xref ref-type="table-fn" rid="table-fn2-1947601912473477">?</xref>)</td>
<td><xref ref-type="bibr" rid="bibr62-1947601912473477">62</xref></td>
</tr>
<tr>
<td>USP9x</td>
<td>USP/<italic>UBL, USP</italic></td>
<td>M</td>
<td>Regulation of chromosome alignment and segregation by controlling the dynamic dissociation of Survivin from centromeres</td>
<td>Survivin</td>
<td><xref ref-type="bibr" rid="bibr125-1947601912473477">125</xref></td>
</tr>
<tr>
<td>UBPY</td>
<td>USP, <italic>MIT, Rhodanese, USP</italic></td>
<td>M</td>
<td>Deubiquitination of proteins (including VAMP8) during cytokinesis</td>
<td>VAMP8, other substrates</td>
<td><xref ref-type="bibr" rid="bibr148-1947601912473477">148</xref></td>
</tr>
<tr>
<td>AMSH</td>
<td>JAMM/MPN+, <italic>MIT</italic></td>
<td>M</td>
<td>Deubiquitination of proteins (including VAMP8) during cytokinesis</td>
<td>VAMP8, other substrates</td>
<td><xref ref-type="bibr" rid="bibr148-1947601912473477">148</xref></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1947601912473477">
<p>The table depicts DUBs known to be involved in cell cycle progression at different cell cycle stages (S [S phase], G1, G2, and M [mitosis]) and transitions. The role and regulation of mitotic DUBs are described in detail in the text. The domain composition and specific substrates of the DUBs are depicted.</p>
</fn>
<fn id="table-fn2-1947601912473477">
<label>?</label>
<p>indicates unconfirmed speculation.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Recent mass spectrometry experiments suggest that as many as 5,000 of ubiquitinated substrate proteins may exist in human cells, with 19,000 possible modification sites.<sup><xref ref-type="bibr" rid="bibr32-1947601912473477">32</xref></sup> Thus, evolutionary pressure could exist that allowed for expansion of the DUB family, ensuring a high level of specificity of these enzymes. Indeed, inactivation of many DUBs leads to very specific phenotypes in cells and organisms, which could arise from the ability of these enzymes to recognize and bind specifically to the diverse ubiquitination signals (<xref ref-type="fig" rid="fig1-1947601912473477">Fig. 1</xref>).</p>
</sec>
<sec id="section4-1947601912473477">
<title>DUBs Reversing Nonproteolytic Ubiquitination Signal</title>
<sec id="section5-1947601912473477">
<title>USP44</title>
<p>The SAC ensures that mitosis does not go beyond metaphase until all chromosomal kinetochores are correctly attached to spindle microtubules, allowing for faithful chromosome segregation and partition of genetic information between the two daughter cells. Both occupancy of kinetochores by the spindle microtubules and tension generated by bipolar attachment between sister kinetochores are sensed by the SAC.<sup><xref ref-type="bibr" rid="bibr18-1947601912473477">18</xref></sup> Activated SAC inhibits the APC/C E3-ubiquitin ligase by sequestering its major mitotic co-activator, CDC20 protein.<sup><xref ref-type="bibr" rid="bibr33-1947601912473477">33</xref>,<xref ref-type="bibr" rid="bibr34-1947601912473477">34</xref></sup> This is achieved by formation of the mitotic checkpoint complex (MCC) composed of the main effector SAC protein, MAD2, along with BubR1, Bub3, and CDC20.<sup><xref ref-type="bibr" rid="bibr35-1947601912473477">35</xref></sup> Binding of MAD2 to CDC20 occurs at unattached kinetochores, but many other regulatory checkpoint components are required to ensure and strengthen the inhibitory effect of the SAC. Attachment of all kinetochores releases SAC inhibition, allowing APC/C<sup>CDC20</sup> to target Securin (inhibitor of sister chromatid separation) and Cyclin B proteins for proteolytic ubiquitination, leading to the anaphase onset and mitotic exit. Stegmeier et al.,<sup><xref ref-type="bibr" rid="bibr36-1947601912473477">36</xref></sup> aiming to identify novel components of SAC in human cells, screened a shRNA library targeting approximately 800 genes related to ubiquitin-signaling for their ability to bypass the spindle checkpoint arrest induced by microtubule poison paclitaxel. One of the identified hits was the DUB, USP44. Indeed, co-transfection of the USP44 siRNA and the siRNA-resistant construct of wild-type USP44 (but not catalytically inactive enzyme) results in rescue of the spindle checkpoint defect. Moreover, inactivation of USP44 in untreated cells leads to premature anaphase onset and chromosomal segregation defects, suggesting that deubiquitinating activity of USP44 is required for efficient SAC signaling and anaphase timing. Intriguingly, SAC defect observed in USP44-depleted cells was not caused by a defect in kinetochore recruitment of checkpoint components. Instead, binding of MAD2 to APC/C<sup>CDC20</sup> was perturbed in these cells, suggesting that USP44 maintains the mitotic arrest by stabilizing the association between MAD2 and CDC20. Interestingly, in another parallel study, APC/C-dependent, nonproteolytic ubiquitination of CDC20 has been shown to be responsible for the disassembly of the MAD2-CDC20 complexes.<sup><xref ref-type="bibr" rid="bibr37-1947601912473477">37</xref></sup> This CDC20 ubiquitination event is mediated by the UbcH10 E2-conjugating enzyme and is required for activation of the APC/C. Consistent with these findings, Stegmeier et <italic>al.</italic> have shown that in mitotic extracts, USP44 inhibits the ubiquitination activity of APC/C. Consequently, inactivation of UbcH10 in USP44-depleted cells leads to reduction of ubiquitinated CDC20, restoration of MAD2-CDC20 association, and rescue of the mitotic checkpoint arrest. These results suggest that USP44 acts as an antagonist of UbcH10 toward APC/C’s own-dependent ubiquitination of CDC20. Thus, the SAC is regulated through a dynamic balance of APC/C-dependent nonproteolytic ubiquitination and USP44-dependent deubiquitination. During final stages of metaphase, when not all chromosomal kinetochores are occupied by spindle microtubules, the SAC is activated through a USP44-dependent “safeguard” mechanism, which by deubiquitinating CDC20 stabilizes MAD2-CDC20 complexes. Thus, the SAC is built on two antagonistic pathways, which can switch rapidly from one to the other, sensing the occupancy state of microtubules on kinetochores.</p>
<p>How is this fine balance between ubiquitination and deubiquitination of CDC20 regulated? It has been shown that USP44 protein levels peak in mitotic cells and are decreased immediately after chromosome attachment to mitotic spindles.<sup><xref ref-type="bibr" rid="bibr36-1947601912473477">36</xref></sup> Moreover, USP44 is also phosphorylated in early mitosis and immediately dephosphorylated after SAC satisfaction but before degradation of Cyclin B. The RNA polymerase II carboxy terminal domain phosphatase, Fcp1, has been shown to mediate dephosphorylation of USP44.<sup><xref ref-type="bibr" rid="bibr38-1947601912473477">38</xref></sup> Fcp1 is a transcription regulator, and it has been shown to be an antagonist to CDK1 in <italic>Aspergillus nidulans</italic>,<sup><xref ref-type="bibr" rid="bibr39-1947601912473477">39</xref></sup> where expression of a defective Fcp1 allele together with an inhibitory phosphorylation-resistant CDK1 allele induced severe mitotic defects including impaired nuclear separation. Mitotic extracts have been used to show that the phosphorylation status of USP44 modulates its activity: Dephosphorylation by Fcp1 leads to the reduction of USP44 activity, which is associated with a dramatic decrease of the MAD2-CDC20 association and mitotic exit. Thus, the phosphorylation status of USP44 may govern the dynamic balance between ubiquitination and deubiquitination of CDC20.</p>
<p>The model by Stegmeier et al.<sup><xref ref-type="bibr" rid="bibr36-1947601912473477">36</xref></sup> of the mitotic checkpoint regulation by antagonistic ubiquitination and deubiquitination has been challenged by another study.<sup><xref ref-type="bibr" rid="bibr40-1947601912473477">40</xref></sup> According to this work, in checkpoint-activated HeLa cells, CDC20 is ubiquitinated by APC/C, leading to its proteasomal degradation. Indeed, ubiquitination-dependent degradation of yeast Cdc20 homolog during activated checkpoint has been demonstrated in <italic>Saccharomyces cerevisae</italic>.<sup><xref ref-type="bibr" rid="bibr41-1947601912473477">41</xref></sup> Moreover, a CDC20 lysine-less mutant allows the inhibition of the mitotic checkpoint by promoting the mitotic exit, which is more consistent with the model in which ubiquitination-dependent degradation of CDC20 maintains the SAC.<sup><xref ref-type="bibr" rid="bibr40-1947601912473477">40</xref></sup> This mitotic exit does not happen immediately, as it has been shown in checkpoint-arrested cells expressing the CDC20 lysine-less mutant, as these cells have an active SAC during at least 2 hours, suggesting that additional ubiquitin-independent mechanism is required to sustain the checkpoint arrest. Reddy et <italic>al.</italic><sup><xref ref-type="bibr" rid="bibr37-1947601912473477">37</xref></sup> have also observed a partial proteolysis of CDC20 upon addition of UbcH10 and ubiquitin on checkpoint-arrested extracts; however, this proteolysis event does not regulate stability of the MCC complex. The other point is that the CDC20 lysine-less mutant binds more strongly to the checkpoint proteins MAD2 and BubR1 than the wild-type CDC20 in checkpoint-arrested cells, suggesting that CDC20 ubiquitination could modulate the binding to MAD2 and BubR1 as suggested by the model of Stegmeier et <italic>al</italic>. However, Nilsson et <italic>al.</italic><sup><xref ref-type="bibr" rid="bibr40-1947601912473477">40</xref></sup> argued that this strong association between the CDC20 lysine-less variant, MAD2, and BubR1 is due to an increased affinity upon the exchange of a conserved lysine into the arginine residue in the MAD2 binding site of CDC20. In principle, two mechanisms of maintaining the SAC signaling are not mutually exclusive and could work at the same time: CDC20 associated with the MCC components could be ubiquitinated by APC/C, allowing its dissociation from the MCC, and it would be degraded subsequently by the proteasome. In such a scenario, CDC20 should be progressively modified by two different types of ubiquitin signal: first a nonproteolytic and then proteolytic one. The action of USP44 would be required to “proofread” ubiquitination status of CDC20 and prevent assembly of inappropriate ubiquitin chains. Thus, future studies need to clarify the type of ubiquitin signals present on CDC20 during the precise time periods of SAC response. Interestingly, overexpression of USP44 in mouse embryonic cells has been shown to increase the association between MAD2 and CDC20 and to lead to an anaphase delay consistent with role of USP44 in the regulation of SAC.<sup><xref ref-type="bibr" rid="bibr42-1947601912473477">42</xref></sup></p>
</sec>
<sec id="section6-1947601912473477">
<title>CYLD</title>
<p>The same shRNA-based screen that led to identification of USP44 revealed the role of another DUB, CYLD, as a regulator of early mitotic phases.<sup><xref ref-type="bibr" rid="bibr43-1947601912473477">43</xref></sup> Mutations in the tumor suppressor gene <italic>CYLD</italic> cause genetic predisposition to human familial cylindromatosis,<sup><xref ref-type="bibr" rid="bibr44-1947601912473477">44</xref></sup> and CYLD deubiquitinating enzyme was shown to negatively regulate NFκB, JNK,<sup><xref ref-type="bibr" rid="bibr45-1947601912473477">45</xref><xref ref-type="bibr" rid="bibr46-1947601912473477"/>-<xref ref-type="bibr" rid="bibr47-1947601912473477">47</xref></sup> and Wnt signaling pathways.<sup><xref ref-type="bibr" rid="bibr48-1947601912473477">48</xref></sup> Some <italic>in vitro</italic> studies have suggested that CYLD is able to cleave specifically K63-linked and linear ubiquitin chains.<sup><xref ref-type="bibr" rid="bibr49-1947601912473477">49</xref></sup> In the study by Stegmeier <italic>et al.</italic>,<sup><xref ref-type="bibr" rid="bibr43-1947601912473477">43</xref></sup> CYLD knockdown led to accumulation of nonmitotic cells after paclitaxel treatment. These cells had a normal interphase nuclear morphology rather reflecting a delay in the mitotic entry process. This phenotype was independent of the regulatory function of CYLD in the NFκB pathway. The premitotic arrest phenotype is rescued by the expression of wild-type CYLD but not an inactive CYLD mutant, suggesting that deubiquitinating activity of CYLD is required for its early mitotic function. Consistently, CYLD-depleted cells are characterized by delayed accumulation of Serine 10-phosphorylated histone H3, delay in phosphorylation of CDC25C, and delayed degradation of Emi1. Intriguingly, downregulation of the mitotic kinase, Polo-like kinase 1 (PLK1), led to the same phenotypes and delayed both CDC25C phosphorylation and mitotic entry.<sup><xref ref-type="bibr" rid="bibr50-1947601912473477">50</xref><xref ref-type="bibr" rid="bibr51-1947601912473477"/>-<xref ref-type="bibr" rid="bibr52-1947601912473477">52</xref></sup> Interestingly, PLK1 has been identified as a binding protein of CYLD using proteomic approaches, suggesting a cooperative role of both proteins in the early mitotic pathway. To give a functional explanation for the delayed entry into mitosis in CYLD-downregulated cells, the authors argued that CYLD could be involved in the “prophase” checkpoint, which has been proposed to regulate entry into early mitotic phases<sup><xref ref-type="bibr" rid="bibr53-1947601912473477">53</xref></sup> and which delays chromosome condensation in response to impaired microtubule structure. The key component of this pathway is CHFR (checkpoint with FHA and RING domains), which is an E3-ubiquitin ligase.<sup><xref ref-type="bibr" rid="bibr54-1947601912473477">54</xref><xref ref-type="bibr" rid="bibr55-1947601912473477"/>-<xref ref-type="bibr" rid="bibr56-1947601912473477">56</xref></sup> It has been shown that <italic>in vitro</italic>, CHFR is able to generate K63-linked ubiquitin chains in cooperation with the E2 conjugating heterodimer Ubc13-MMS.<sup><xref ref-type="bibr" rid="bibr56-1947601912473477">56</xref></sup> Thus, it is tempting to propose that CYLD antagonizes the CHFR activity in order to restart the progression of the cell cycle after resolving microtubule defects. Indeed, based on experiments with <italic>Xenopus</italic> egg extracts, it has been proposed that PLK1 is ubiquitinated by CHFR and then degraded in order to establish a delay in the entry of mitosis upon mitotic stress.<sup><xref ref-type="bibr" rid="bibr54-1947601912473477">54</xref></sup> Whether CHFR ubiquitinates PLK1 in cells and which kind of ubiquitin signal is used are not known. Alternatively, other, unknown components of the prophase checkpoint signaling modified by CHFR-mediated K63-linked ubiquitination could be direct potential substrates of CYLD. Thus, further studies are required to confirm the involvement of CYLD in the prophase checkpoint.</p>
<p>Interestingly, it has been shown that stable expression of CYLD in U2OS cells results in an increase of fragmented nuclei and multinucleated cells, reflecting impairment in chromosome segregation and/or cytokinesis.<sup><xref ref-type="bibr" rid="bibr43-1947601912473477">43</xref></sup> Furthermore, localization analysis has shown that overexpressed CYLD is associated with microtubules in interphase and at the midbody in telophase stage, suggesting another potential mitotic function of CYLD. Consistent with these observations, in addition to its USP domain, CYLD contains 3 cytoskeletal-associated protein-glycin-conserved (CAP-Gly) repeats. CAP-Gly domain is a conserved motif found in a large number of microtubule-associated proteins and could explain microtubule localization of CYLD. Indeed, CYLD interacts with the microtubule subunit tubulin through its two first CAP-Gly independent of its deubiquitinating activity.<sup><xref ref-type="bibr" rid="bibr57-1947601912473477">57</xref>,<xref ref-type="bibr" rid="bibr58-1947601912473477">58</xref></sup> This interaction could allow regulation of the microtubules’ dynamics by CYLD, as CYLD depletion in HeLa cells induces a slow microtubule regrowth after nocodazole treatment,<sup><xref ref-type="bibr" rid="bibr57-1947601912473477">57</xref></sup> and its overexpression leads to accelerated microtubule regrowth in melanoma cells.<sup><xref ref-type="bibr" rid="bibr58-1947601912473477">58</xref></sup> Furthermore, the midbody localization of CYLD has been confirmed at the level of endogenous protein in primary mouse keratinocytes.<sup><xref ref-type="bibr" rid="bibr58-1947601912473477">58</xref></sup> Because many proteins involved in the regulation of cytokinesis are localized to the midbody, CYLD could have a potential function in this process. It has been shown that CYLD co-localizes at the midbody with the histone deacetylase HDAC6, leading to its inhibition and high levels of acetylated, more stable microtubules, suggesting that CYLD could participate in the regulation of microtubule dynamics during the final stages of cytokinesis. However, since CYLD’s role in regulation of acetylation status of microtubules does not involve its deubiquitinating activity, it is not clear how exactly CYLD exerts its function at the midbody at the mechanistic level.</p>
<p>However, CYLD seems also to play a role in the assembly of the mitotic spindle.<sup><xref ref-type="bibr" rid="bibr59-1947601912473477">59</xref></sup> This function could be linked to the interaction of CYLD with the centrosomal protein CEP192, which is involved in the centrosome maturation and nucleation of microtubules.<sup><xref ref-type="bibr" rid="bibr60-1947601912473477">60</xref>,<xref ref-type="bibr" rid="bibr61-1947601912473477">61</xref></sup> In CEP192-depleted cells, microtubules are assembled in the vicinity of chromosomes and are unable to self-organize into bipolar spindles. Co-depletion of CEP192 and CYLD alleviates the spindle assembly defects, suggesting that CYLD function could be inhibited by CEP192. Because CYLD regulates microtubule dynamics in interphase cells, Gomez-Ferreria et <italic>al.</italic><sup><xref ref-type="bibr" rid="bibr59-1947601912473477">59</xref></sup> proposed that the potential inhibition of CYLD by CEP192 could take place at the onset of mitosis to allow for depolymerization of microtubules and/or to maintain possible K63-linked ubiquitination-mediated interaction(s) necessary for the spindle assembly.</p>
<p>Taken together, CYLD appears to fulfill some important functions during both early mitotic stages and mitotic exit. Further studies are needed to identify the specific and direct targets of this DUB as well as the precise modes of its regulation during mitosis.</p>
</sec>
<sec id="section7-1947601912473477">
<title>USP39 and USP4</title>
<p>Using a RNAi-based screen, van Leuken <italic>et al.</italic><sup><xref ref-type="bibr" rid="bibr62-1947601912473477">62</xref></sup> identified USP39 as another regulator of the SAC. Knockdown of USP39 in synchronized U2OS cells leads to an increase in the cellular DNA content reflecting a defect in chromosome segregation and/or cytokinesis. Interestingly, the USP39-depleted cells were able to bypass the mitotic arrest induced by treatment with a microtubule stabilizing drug, paclitaxel, but not by nocodazole, which induces microtubule depolymerization. As mentioned previously, SAC is activated not only by the presence of unattached kinetochores but also by a lack of tension exerted across sister centromeres. Indeed, paclitaxel decreases the interkinetochore tension, suggesting that USP39 is specifically required to sustain the tension-dependent branch of the SAC. USP39 is also known as a 65 kDa SR-related protein of the U4/U6.U5 tri-snRNP. It associates with small ribonuclear proteins and is involved in the splicing process.<sup><xref ref-type="bibr" rid="bibr63-1947601912473477">63</xref></sup> van Leuken <italic>et al.</italic><sup><xref ref-type="bibr" rid="bibr62-1947601912473477">62</xref></sup> found that depletion of USP39 leads to a decrease of the mRNA levels of the mitotic kinase Aurora B and consequently its protein levels. Ectopic transfection of Aurora B cDNA restored Aurora B protein levels in USP39-depleted cells but failed to rescue the mitotic arrest upon paclitaxel treatment. These observations suggested that USP39 is a critical regulator of the tension-dependent mitotic checkpoint through its function in the splicing of the Aurora B mRNA and possibly other mRNAs of essential mitotic factors. Aurora B kinase is a catalytic component of the so-called chromosomal passenger complex (CPC), containing INCENP, Survivin, Borealin/Dasra B, and Telophase-Disc-60 (TD60) proteins. Aurora B is able to correct erroneous microtubule-kinetochore attachments in particular monotelic and syntelic attachments where not enough tension is generated between sister chromatids.<sup><xref ref-type="bibr" rid="bibr64-1947601912473477">64</xref><xref ref-type="bibr" rid="bibr65-1947601912473477"/>-<xref ref-type="bibr" rid="bibr66-1947601912473477">66</xref></sup></p>
<p>Although USP39 contains an ubiquitin-protease domain, the cysteine and histidine residues belonging to the catalytic triad of the DUB’s cysteine-protease are not conserved, and consequently the authors have reported absence of the catalytic activity of USP39 <italic>in vitro</italic>. Despite the fact that USP39 might be catalytically inactive, it could participate in an important molecular pathway. Indeed, other studies have postulated that some DUBs do exert a function in a noncatalytic manner. For example, OTUB1 inhibits DNA double-strand breaks independently of its catalytic activity,<sup><xref ref-type="bibr" rid="bibr67-1947601912473477">67</xref></sup> and yeast Ubp6 is involved in regulation of the proteasome-dependent degradation in a noncatalytic manner.<sup><xref ref-type="bibr" rid="bibr68-1947601912473477">68</xref></sup> These studies highlight the possibility that DUBs that have been predicted to be inactive, such as USP50 and USP52 to 54,<sup><xref ref-type="bibr" rid="bibr69-1947601912473477">69</xref></sup> exert noncanonical DUB functions, possibly by acting as ubiquitin-binding receptors rather than processing enzymes.</p>
<p>Another elegant study demonstrated the role of splicing in SAC signaling and identified DUB USP4 as a regulator of the spliceosome function during SAC response induced by treatments with paclitaxel and monastrol (a specific inhibitor of kinesin Eg5 required for formation of bipolar spindles).<sup><xref ref-type="bibr" rid="bibr70-1947601912473477">70</xref></sup> Downregulation of USP4 leads to SAC bypass after these treatments, and mRNA levels of α-tubulin (constituent of microtubules) and Bub1 (SAC protein) are reduced in these cells. The assembly of spliceosome is initiated by binding of the U1 snRNP to the 5′ splice site followed by recognition of the branch point site and 3′ splice site by SF1/BBP and U2AF, respectively.<sup><xref ref-type="bibr" rid="bibr71-1947601912473477">71</xref></sup> The prespliceosome is formed after recruitment of the U2 snRNP. The U4/U6 and U5 snRNPs are then added as preassembled U4/U6.U5 tri-snRNP to form an inactive complex. Upon release of U1 and U4 snRNPs, splicing reactions start. After the mRNA splicing, the spliceosome is disassembled, allowing another round of splicing. USP4 together with its substrate targeting factor, the U4/U6 recycling factor Sart3, is able to deubiquitinate the Prp3 protein,<sup><xref ref-type="bibr" rid="bibr70-1947601912473477">70</xref></sup> which is a component of the U4 snRNP. Prp3 ubiquitination is catalyzed by the U- box-containing protein Prp19, which is a member of the Prp19 complex (Nine Teen Complex, or NTC). In yeast, this complex participates in the splicing process by influencing the biogenesis of U4/U6 snRNP and stabilizing the binding of U5 and U6 snRNPs on the spliceosome after U4 release.<sup><xref ref-type="bibr" rid="bibr72-1947601912473477">72</xref>,<xref ref-type="bibr" rid="bibr73-1947601912473477">73</xref></sup> The ubiquitination signal of the Prp3 protein is nonproteolytic, and these K63-linked ubiquitin chains are then recognized by the U5 snRNP component, Prp8. Indeed, it has been previously shown that yeast Prp8 is able to bind ubiquitin <italic>in vitro</italic> through its variant Jab1/MPN domain.<sup><xref ref-type="bibr" rid="bibr74-1947601912473477">74</xref></sup> This interaction is necessary for the stabilization of the U4/U6.U5 tri-snRNP, confirming previous study about the requirement of ubiquitin for U4/U6.U5 stability.<sup><xref ref-type="bibr" rid="bibr75-1947601912473477">75</xref></sup> The working model suggests that Prp3 ubiquitination acts on U4/U6.U5 stabilization during the formation of inactive spliceosomal complex. After recruitment of the U4/U6.U5 tri-snRNP to the spliceosome, USP4-Sart3 deubiquitinates Prp3, facilitating the release of the U4 snRNP necessary for activation of the splicing machinery. To highlight the requirement of splicing for the fidelity of cell division, Song et <italic>al.</italic><sup><xref ref-type="bibr" rid="bibr70-1947601912473477">70</xref></sup> showed that depletion of several other spliceosomal factors leads to mitotic defects in HeLa cells treated with paclitaxel drug. Interestingly, knockdown of the 65 kDa SR-related protein of the U4/U6.U5 tri-snRNP, USP39, is responsible for the SAC bypass, confirming results obtained by van Leuken et <italic>al</italic>.<sup><xref ref-type="bibr" rid="bibr62-1947601912473477">62</xref></sup> Thus, USP39 and USP4 regulate splicing and are indirect but critical regulators of the mitosis.</p>
<p>Altogether, these studies suggest that splicing is a very dynamic process and that the spliceosome is a subject of constant and profound conformational rearrangements. Throughout the splicing cycle, distinct RNAs and proteins are assembled and disassembled at precise time points. Thus, modifications of proteins by ubiquitination allow for modulation of these highly dynamic rearrangements in the spliceosome composition. Both reversibility of ubiquitin modification and binding of the specific ubiquitin receptor proteins to the nonproteolytic ubiquitin chains allow for regulation of stable protein complexes and subcomplexes during splicing. These studies also highlight the possibility that other dynamic cellular processes could be regulated by ubiquitination of the splicing machinery.</p>
<p>Interestingly, the <italic>usp4</italic> gene belongs to a chromosomal region that is frequently deleted in small-cell lung cancer (SCLC). Furthermore, SCLC is associated with reduced expression of USP4<sup><xref ref-type="bibr" rid="bibr76-1947601912473477">76</xref></sup> and alterations of ploidy.<sup><xref ref-type="bibr" rid="bibr77-1947601912473477">77</xref></sup> Because defects in the SAC often lead to increase in polyploidization, loss of USP4 could be linked to tumorigenesis.</p>
</sec></sec>
<sec id="section8-1947601912473477">
<title>DUB Reversing Proteolytic Ubiquitination Signal</title>
<sec id="section9-1947601912473477">
<title>USP37</title>
<p>Irreversible degradation by the ubiquitin-proteasome system confers directionality of the cell cycle. The APC/C E3 ligase together with its co-activators (CDC20 and CDH1) orchestrates cell cycle progression through mitosis and G1 phases<sup><xref ref-type="bibr" rid="bibr6-1947601912473477">6</xref></sup> (<xref ref-type="fig" rid="fig2-1947601912473477">Fig. 2</xref>). The CDC20 activates APC/C during mitotic phases, whereas CDH1 activates APC/C as cells exit mitosis and in G1 phase. This sequential activation manner, also referred to as “substrate ordering,” allows the temporal order of degradation of APC/C substrates such as Cyclin A, Securin, Cyclin B, Geminin, PLK1, and Aurora A<sup><xref ref-type="bibr" rid="bibr78-1947601912473477">78</xref></sup> and ensures faithful cell cycle progression. By counterbalancing the activities of E3 ubiquitin ligases, DUBs could be involved in the timing of degradation of the ubiquitination substrates. To identify potential DUBs implicated in the regulation of substrates of APC/C, Huang et <italic>al</italic>.<sup><xref ref-type="bibr" rid="bibr79-1947601912473477">79</xref></sup> used a proteomic approach. Interestingly, USP37 has been found to interact specifically with the co-activator CDH1 but not with CDC20.<sup><xref ref-type="bibr" rid="bibr79-1947601912473477">79</xref></sup> Furthermore, APC/C subunits such as CDC27, APC5, and APC7 co-immunoprecipitated with the endogenous USP37, and interaction with CDC27 is decreased upon CDH1 knockdown, suggesting that USP37 binds to APC/C through the CDH1 co-activator. Interestingly, overexpression of USP37 in synchronized U2OS cells led to an accumulation of Cyclin A protein level, which could reflect a reduced rate of its proteasomal degradation. Moreover, USP37-overexpressing cells are also characterized by an accelerated entry into S phase. Conversely, cells expressing specific USP37 shRNAs exhibited a delay in accumulation of Cyclin A after release from nocodazole-induced mitotic block and were also delayed for the entry into S phase. Thus, USP37 may regulate turnover of Cyclin A and thereby G1/S transition. Furthermore, Huang et <italic>al</italic>.<sup><xref ref-type="bibr" rid="bibr79-1947601912473477">79</xref></sup> have also demonstrated that endogenous USP37 is able to bind to Cyclin A, suggesting that Cyclin A could be a direct USP37 substrate. Indeed, unlike catalytically inactive mutant, the wild-type form of USP37 is able to reduce ubiquitination of Cyclin A in cells and to counterbalance the activity of APC/C<sup>CDH1</sup> <italic>in vitro</italic>.<sup><xref ref-type="bibr" rid="bibr79-1947601912473477">79</xref></sup> These results strongly establish USP37 as an antagonist of APC/C<sup>CDH1</sup> toward ubiquitination of Cyclin A, allowing for rescue from its proteasomal degradation and faithful progression beyond the G1/S transition. However, how is the function of USP37 regulated to ensure temporal specificity? By analyzing the USP37 protein levels, the authors observed that USP37 fluctuates in a cell cycle–dependent manner. USP37 levels peaked in the late G1 phase, decreased in late mitosis, and reappeared in G1 again, reflecting a typical profile of degradation events governed by APC/C<sup>CDH1</sup> at the M/G1 transition. It is known that APC/C<sup>CDH1</sup> recognizes substrates via short D- or KEN-box motives.<sup><xref ref-type="bibr" rid="bibr80-1947601912473477">80</xref>,<xref ref-type="bibr" rid="bibr81-1947601912473477">81</xref></sup> Indeed, USP37 contains a KEN-box motif necessary for the K11-linked ubiquitination mediated by APC/C<sup>CDH1</sup> and its subsequent degradation. Interestingly, USP37 is also able to rescue itself from degradation in late G1. Thus, USP37 acts as an APC/C<sup>CDH1</sup> substrate in late mitosis, and it counterbalances the APC/C<sup>CDH1</sup> activity toward itself and Cyclin A in late G1. These opposing functions are modulated by CDK2-mediated phosphorylation of USP37. In their working model, the authors present evidence that Cyclin E-CDK2 phosphorylates USP37 in late G1, resulting in its activation and its rescue from degradation. USP37 acts also on ubiquitinated Cyclin A, which in turn associates with CDK2 and amplifies the activation of USP37. This positive feedback loop promotes the G1/S transition. The USP37 activation is reinforced by phosphorylation-dependent inhibition of APC/C<sup>CDH1</sup> by Cyclin A-CDK2.<sup><xref ref-type="bibr" rid="bibr82-1947601912473477">82</xref></sup> In late mitosis, cyclin partners were degraded, preventing phosphorylation-mediated activation of USP37. At the same time, activated APC/C<sup>CDH1</sup> is responsible of the proteolytic ubiquitination of USP37. The work by Huang et <italic>al.</italic> nicely illustrates the dynamic interplay between a DUB and E3-ubiquitin ligase, which is necessary for timely regulation of the key cell cycle regulators. In a recent proteomic survey it was found that indeed many DUBs associate with E3-ligase complexes,<sup><xref ref-type="bibr" rid="bibr83-1947601912473477">83</xref></sup> suggesting that cross-regulation observed between USP37 and APC/C<sup>CDH1</sup> could be a commonly used mechanism for spatiotemporal regulation of other important biological pathways. It will be interesting to understand whether additional DUBs exist that specifically counteract ubiquitination of some of the other numerous targets of APC/C. Likewise, the role of putative novel DUBs that may act on substrates of the SCF E3-ligases during early mitotic phases, and targets of the recently described CUL3-based E3-ligases coordinating mitotic progression, are currently unknown.</p>
<p>Recently, Burrows et al.<sup><xref ref-type="bibr" rid="bibr84-1947601912473477">84</xref></sup> demonstrated that USP37 is also subjected to a second wave of degradation during the cell cycle. Indeed, a fraction of USP37 is degraded by the SCF<sup>βTrCP</sup> E3 ligase at the G2/M transition. This degradation event requires a PLK1-dependent phosphorylation at a noncanonical degron within the sequence of USP37. Interestingly, the expression of a SCF<sup>βTrCP</sup>-resistant USP37 mutant leads to a delay of the mitotic entry, suggesting that one of the USP37 pools regulates unknown substrates required for the inhibition of entry into mitosis. This USP37 pool does not seem to regulate Cyclin A.<sup><xref ref-type="bibr" rid="bibr84-1947601912473477">84</xref></sup> Thus, identification of the new USP37 substrate will be essential to understand the cell cycle functions of both USP37 pools.</p>
</sec></sec>
<sec id="section10-1947601912473477">
<title>UBPs in Mitosis</title>
<p>Recognition of ubiquitinated substrates is mediated by a variety of ubiquitin-binding proteins (UBPs) that serve as ubiquitin receptors (or decoders) and contain at least 1 ubiquitin-binding domain (UBD) within their structure.<sup><xref ref-type="bibr" rid="bibr85-1947601912473477">85</xref><xref ref-type="bibr" rid="bibr86-1947601912473477"/>-<xref ref-type="bibr" rid="bibr87-1947601912473477">87</xref></sup> Based on their structural features, UBDs can be divided into several subgroups, such as ubiquitin-associated (UBA) domain, ubiquitin-interacting motif (UIM), motif interacting with ubiquitin (MIU), and many others.<sup><xref ref-type="bibr" rid="bibr88-1947601912473477">88</xref></sup> The common feature of these UBDs is the ability to noncovalently bind ubiquitin moiety. Increasing experimental evidence suggests that UBPs play a critical role in defining the fate of ubiquitinated targets in time and space, either by mediating their proteasomal degradation or by regulating their localization and/or interaction with other proteins. UBPs have recently been also shown to play a role in mitosis (<xref ref-type="fig" rid="fig2-1947601912473477">Fig. 2</xref>). Rad23, Dsk2, Ddi1, and Rpn10 were identified in <italic>Saccharomyces cerevisiae</italic> as regulators of mitotic progression by shuttling ubiquitinated targets to the proteasome for degradation,<sup><xref ref-type="bibr" rid="bibr89-1947601912473477">89</xref><xref ref-type="bibr" rid="bibr90-1947601912473477"/><xref ref-type="bibr" rid="bibr91-1947601912473477"/><xref ref-type="bibr" rid="bibr92-1947601912473477"/>-<xref ref-type="bibr" rid="bibr93-1947601912473477">93</xref></sup> whereas the second group includes UBPs mediating relocalization of its targets involving the Cdc48/p97-Ufd1-Npl4 (p97) complex in mammalian cells. Although the p97 complex was proposed to play a role in chromosome segregation and spindle dynamics,<sup><xref ref-type="bibr" rid="bibr94-1947601912473477">94</xref><xref ref-type="bibr" rid="bibr95-1947601912473477"/>-<xref ref-type="bibr" rid="bibr96-1947601912473477">96</xref></sup> very little is known about specific UBPs controlling mitosis in mammalian cells, in particular the functional homologs of Rad23 pathway. Here, we summarize the role of UBPs controlling cell cycle (<xref ref-type="table" rid="table2-1947601912473477">Table 2</xref>), with the main focus on known yeast UBPs and their unpredicted redundancy in controlling mitotic progression. Furthermore, we discuss the role of human p97 complex during mitosis.</p>
<table-wrap id="table2-1947601912473477" position="float">
<label>Table 2.</label>
<caption>
<p>List of UBPs Regulating Cell Cycle</p>
</caption>
<graphic alternate-form-of="table2-1947601912473477" xlink:href="10.1177_1947601912473477-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Name</th>
<th align="center">Domains</th>
<th align="center">Cell Cycle Stage</th>
<th align="center">Function</th>
<th align="center">Substrate(s)</th>
<th align="center">References</th>
</tr>
</thead>
<tbody>
<tr>
<td>KPC2</td>
<td>UBL-UBA</td>
<td>G1</td>
<td>Cell proliferation control: degradation of the cyclin-dependent kinase inhibitor p27 (cooperatively with KPC1)</td>
<td>p27</td>
<td><xref ref-type="bibr" rid="bibr149-1947601912473477">149</xref>, <xref ref-type="bibr" rid="bibr150-1947601912473477">150</xref></td>
</tr>
<tr>
<td>YEAST RPN10 (Human: PSMD4)</td>
<td>UIM</td>
<td>G1/S M/G1</td>
<td>Proteasome receptor for ubiquitinated substrates, regulates G1/S and M/G1 transition in budding yeast</td>
<td>Clb2, Sic1 (Yeast)</td>
<td><xref ref-type="bibr" rid="bibr91-1947601912473477">91</xref>, <xref ref-type="bibr" rid="bibr110-1947601912473477">110</xref></td>
</tr>
<tr>
<td>Polymerase eta</td>
<td>UBZ</td>
<td>S</td>
<td>Translesion synthesis, tolerance of DNA damage by replicative bypass, negative self-regulation of the activity</td>
<td>PCNA, polymerase eta itself</td>
<td><xref ref-type="bibr" rid="bibr151-1947601912473477">151</xref>, <xref ref-type="bibr" rid="bibr152-1947601912473477">152</xref></td>
</tr>
<tr>
<td>Polymerase kappa</td>
<td>UBZ</td>
<td>S</td>
<td>Translesion synthesis, tolerance of DNA damage by replicative bypass</td>
<td>PCNA</td>
<td><xref ref-type="bibr" rid="bibr153-1947601912473477">153</xref>, <xref ref-type="bibr" rid="bibr154-1947601912473477">154</xref></td>
</tr>
<tr>
<td>Polymerase iota</td>
<td>UBM</td>
<td>S</td>
<td>Translesion synthesis, tolerance of DNA damage by replicative bypass</td>
<td>PCNA</td>
<td><xref ref-type="bibr" rid="bibr155-1947601912473477">155</xref>, <xref ref-type="bibr" rid="bibr156-1947601912473477">156</xref></td>
</tr>
<tr>
<td>Polymerase Rev1</td>
<td>UBM</td>
<td>S</td>
<td>Translesion synthesis, tolerance of DNA damage by replicative bypass</td>
<td>PCNA</td>
<td><xref ref-type="bibr" rid="bibr156-1947601912473477">156</xref></td>
</tr>
<tr>
<td>YEAST DDI1/VSM1</td>
<td>UBL (DDI1), UBA-UBL (VSM1)</td>
<td>G1/S G2/M M</td>
<td>Sister chromatid separation, <italic>Pds1p-dependent S-phase checkpoint control</italic>, degradation of a SCF component, the F-box protein Ufo1, involved in the G1/S transition, spindle dynamics</td>
<td>(<xref ref-type="table-fn" rid="table-fn3-1947601912473477">?</xref>), Pds1p, Ufo1 (Yeast)</td>
<td><xref ref-type="bibr" rid="bibr98-1947601912473477">98</xref>, <xref ref-type="bibr" rid="bibr90-1947601912473477">90</xref>, <xref ref-type="bibr" rid="bibr106-1947601912473477">106</xref>, <xref ref-type="bibr" rid="bibr108-1947601912473477">108</xref></td>
</tr>
<tr>
<td>YEAST: DSK2 (Human: Ubiquilin2, hPLIC1/2)</td>
<td>UBA, UBL</td>
<td>G2/M M</td>
<td>Transfer of the ubiquitylated proteins to the proteasome, spindle pole body duplication, spindle dynamics</td>
<td>(<xref ref-type="table-fn" rid="table-fn3-1947601912473477">?</xref>), Pds1, Kre22 (Yeast)</td>
<td><xref ref-type="bibr" rid="bibr89-1947601912473477">89</xref>, <xref ref-type="bibr" rid="bibr90-1947601912473477">90</xref>, <xref ref-type="bibr" rid="bibr106-1947601912473477">106</xref>, <xref ref-type="bibr" rid="bibr157-1947601912473477">157</xref></td>
</tr>
<tr>
<td>YEAST RAD23 (Human: hRAD23A/B)</td>
<td>UBA, UBL</td>
<td>G2/M M</td>
<td>Metaphase-anaphase transition, spindle pole body duplication, G2/M, sister chromatids separation, spindle dynamics</td>
<td>(<xref ref-type="table-fn" rid="table-fn3-1947601912473477">?</xref>), Pds1p (Yeast)</td>
<td><xref ref-type="bibr" rid="bibr89-1947601912473477">89</xref>, <xref ref-type="bibr" rid="bibr98-1947601912473477">98</xref>, <xref ref-type="bibr" rid="bibr90-1947601912473477">90</xref>, <xref ref-type="bibr" rid="bibr93-1947601912473477">93</xref></td>
</tr>
<tr>
<td>RAP80</td>
<td>IUM</td>
<td>G2/M</td>
<td>BRCA1-dependent DNA damage response and double-strand break repair</td>
<td>“Lys-63”-linked ubiquitinated histones H2A and H2AX at DNA lesions sites</td>
<td><xref ref-type="bibr" rid="bibr158-1947601912473477">158</xref>, <xref ref-type="bibr" rid="bibr159-1947601912473477">159</xref></td>
</tr>
<tr>
<td>Ufd1</td>
<td>NZF</td>
<td>M</td>
<td>Nucleus reformation, chromosome alignment and segregation</td>
<td>Aurora B, Survivin</td>
<td><xref ref-type="bibr" rid="bibr96-1947601912473477">96</xref>, <xref ref-type="bibr" rid="bibr94-1947601912473477">94</xref>, <xref ref-type="bibr" rid="bibr125-1947601912473477">125</xref></td>
</tr>
<tr>
<td>Npl4</td>
<td>NZF</td>
<td>M</td>
<td>Nucleus reformation, chromosome alignment and segregation</td>
<td>Aurora B, Survivin</td>
<td><xref ref-type="bibr" rid="bibr96-1947601912473477">96</xref>, <xref ref-type="bibr" rid="bibr94-1947601912473477">94</xref>, <xref ref-type="bibr" rid="bibr125-1947601912473477">125</xref></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-1947601912473477">
<p>The table depicts UBPs known to be involved in cell cycle progression at different cell cycle stages (S [S phase], G1, G2 and M [mitosis]) and transitions. The role and regulation of mitotic UBPs are described in detail in the text. The predicted human orthologs of these genes are indicated. The domain composition and specific substrates of the UBPs are depicted. <sup>?</sup>indicates unconfirmed speculation.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section11-1947601912473477">
<title>UBPs Targeting Substrates for Proteasomal Degradation</title>
<sec id="section12-1947601912473477">
<title>Rad23, Dsk2, and Ddi1</title>
<p>In yeast <italic>Saccharomyces cerevisiae</italic>, Rad23 and Ddi1 were shown to shuttle ubiquitinated proteins to the 26S proteasome for degradation.<sup><xref ref-type="bibr" rid="bibr93-1947601912473477">93</xref></sup> These proteins belong to UBPs that possess an UBA domain (2 UBA domains in case of Rad23) interacting with ubiquitin and ubiquitinated substrates.<sup><xref ref-type="bibr" rid="bibr97-1947601912473477">97</xref>,<xref ref-type="bibr" rid="bibr98-1947601912473477">98</xref></sup> In addition, Rad23 and Ddi1 have the N-terminal ubiquitin-like domain (UBL) that is able to interact with the proteasome.<sup><xref ref-type="bibr" rid="bibr99-1947601912473477">99</xref>,<xref ref-type="bibr" rid="bibr100-1947601912473477">100</xref></sup> RAD23 and DDI1 genes were initially identified in a screen for suppressors of the temperature sensitive mutant allele of PDS1, pds1-128.<sup><xref ref-type="bibr" rid="bibr90-1947601912473477">90</xref></sup> Pds1 (securin in higher vertebrates) is an essential regulator of mitosis and inhibitor of anaphase onset.<sup><xref ref-type="bibr" rid="bibr101-1947601912473477">101</xref>,<xref ref-type="bibr" rid="bibr102-1947601912473477">102</xref></sup> Proteasomal degradation of Pds1 releases its inhibitory action on Separin, Esp1 (Separase in higher vertebrates) that mediates cleavage of cohesin complex, sister chromatid separation, and anaphase spindle elongation, ensuring successful completion of mitosis in yeast cells.<sup><xref ref-type="bibr" rid="bibr103-1947601912473477">103</xref></sup> Pds1 is polyubiquitinated by APC/C prior to the onset of anaphase, which leads to recognition of the ubiquitin chain by 26S proteasome and degradation of Pds1 at the beginning of anaphase.<sup><xref ref-type="bibr" rid="bibr104-1947601912473477">104</xref></sup> Interestingly, deletions of both RAD23 and DDI1 genes were able to rescue pds1-128 temperature sensitive phenotype, suggesting a possible role of these proteins in the regulation of Pds1 proteolysis during mitosis.<sup><xref ref-type="bibr" rid="bibr90-1947601912473477">90</xref></sup> Furthermore, the mechanism of anaphase control was proposed in which Rad23 and Ddi1 bind ubiquitinated Pds1, thus inhibiting ubiquitin chain elongation and subsequent Pds1 proteolysis.<sup><xref ref-type="bibr" rid="bibr90-1947601912473477">90</xref></sup> It is not known however, what is the mechanism of Rad23-Ddi1-Pds1 complex dissociation that finally leads to Pds1 degradation by proteasome.</p>
<p>The third UBA-UBL protein, Dsk2, was also shown to play a role in governing ubiquitinated substrates to proteasome.<sup><xref ref-type="bibr" rid="bibr99-1947601912473477">99</xref>,<xref ref-type="bibr" rid="bibr105-1947601912473477">105</xref></sup> Overexpression of Dsk2 is toxic for cells due to accumulation of ubiquitinated substrates and leads to mitotic arrest, an abnormal nuclear positioning, and affected spindle dynamics.<sup><xref ref-type="bibr" rid="bibr89-1947601912473477">89</xref>,<xref ref-type="bibr" rid="bibr99-1947601912473477">99</xref></sup> There are controversial data about involvement of Dsk2 in spindle pole body (centrosomes in mammalian cells) duplication. Some studies have proposed a model according to which Dsk2 together with Rad23 assists the assembly of Cdc31 into the spindle pole body, which is considered to be an essential event in its duplication.<sup><xref ref-type="bibr" rid="bibr89-1947601912473477">89</xref></sup> However, a follow-up study has shown that deletion of Rad23 and/or Dsk2, as well as triple deletion of Rad23-Ddi1-Dsk2, did not lead to the spindle pole body duplication failure.<sup><xref ref-type="bibr" rid="bibr106-1947601912473477">106</xref></sup> Interestingly, it has been shown that Rad23, Ddi1, and Dsk2 exert partially redundant roles in cell cycle progression.<sup><xref ref-type="bibr" rid="bibr106-1947601912473477">106</xref></sup> Double deletions of Rad23-Dsk2 and Rad23-Ddi1 showed slight accumulation of cells in G2/M; however, single deletions of these 3 genes and also double deletion of Ddi1-Dsk2 did not show any defect in mitotic progression. Furthermore, triple deletion Rad23-Ddi1-Dsk2 led to striking cell cycle arrest either in G2 or in anaphase. Additionally, spindle dynamics were shown to be affected in triple deletion strain; however, the underlying mechanisms still remain unclear.<sup><xref ref-type="bibr" rid="bibr106-1947601912473477">106</xref></sup> According to these results, Rad23 shares a common function with Ddi1 and Dsk2 in mitotic control, but it is not clear how these proteins are regulated to coordinate the common tasks. One possible level of such regulation that could allow for specificity in binding of the ubiquitinated substrates is formation of both homo- and heterodimers between Rad23, Ddi1, and Dsk2 proteins.<sup><xref ref-type="bibr" rid="bibr105-1947601912473477">105</xref>,<xref ref-type="bibr" rid="bibr107-1947601912473477">107</xref></sup> UBA and/or UBL domains were shown to be essential in Rad23 and Dsk2 homodimerization and Rad23 heterodimerization with Dsk2 and Ddi1.<sup><xref ref-type="bibr" rid="bibr93-1947601912473477">93</xref>,<xref ref-type="bibr" rid="bibr107-1947601912473477">107</xref>,<xref ref-type="bibr" rid="bibr108-1947601912473477">108</xref></sup> According to one of the proposed models, dimerization of UBA/UBL proteins can potentially play a role in preventing unnecessary ubiquitin chain elongation or premature disassembly during the transit of substrates to the proteasome: Polyubiquitin chain of a substrate might be tightly covered with a complex containing multiple UBA domains, thus blocking access of E3-ligases and/or deubiquitinated enzymes to the substrate.<sup><xref ref-type="bibr" rid="bibr93-1947601912473477">93</xref></sup> However, the biological significance of UBPs dimerization still remains to be determined experimentally.</p>
<p>In addition to the role in mitosis, Ddi1 was shown to be implicated in the negative regulation of the late secretory pathway by interacting with exocytic v- and t-SNAREs.<sup><xref ref-type="bibr" rid="bibr108-1947601912473477">108</xref></sup> It is not yet clear how Ddi1 coordinates both processes, in particular, which stimuli can possibly serve as a switch between these two functions by regulating the change in localization of Ddi1 in the cell (either on a plasma membrane or in the nucleus).</p>
<p>Taken together, these results suggest a role of UBA-UBL proteins Rad23, Ddi1, and Dsk2 in controlling mitotic progression. These proteins were shown to inhibit degradation of ubiquitinated Pds1, thus delaying the onset of anaphase, and to influence spindle dynamics. The regulatory functions of UBPs are complicated by redundancy and cooperation between ubiquitin receptors. Thus, the exact mechanisms of mitotic control by Rad23, Ddi1 and Dsk2 remain to be elucidated. Future studies are needed to identify other yet unknown targets of Rad23-Ddi1-Dsk2 proteins that play a role during mitotic progression. Likewise, the functional orthologs of this pathway in higher vertebrates need to be characterized.</p>
</sec>
<sec id="section13-1947601912473477">
<title>Rpn10</title>
<p>The Rad23-pathway components are not the only UBPs known to play a role in the regulation of mitosis in yeast. Another UBP, Rpn10, was shown to play a role in determining the fate of critical mitotic factors. Rpn10 is a stoichiometric component of 26S proteasome, and it was predicted to be one of the ubiquitin receptors governing ubiquitinated proteins for degradation.<sup><xref ref-type="bibr" rid="bibr109-1947601912473477">109</xref>,<xref ref-type="bibr" rid="bibr110-1947601912473477">110</xref></sup> Rpn10 contains 2 domains: N-terminal von Willebrand A domain, which is necessary for interaction with proteasome, and C-terminal ubiquitin-interacting motif (UIM) domain, which ensures Rpn10 binding to the ubiquitinated targets. Among other targets, Rpn10 controls turnover and degradation of one of the key cell cycle regulators, Sic1.<sup><xref ref-type="bibr" rid="bibr91-1947601912473477">91</xref>,<xref ref-type="bibr" rid="bibr110-1947601912473477">110</xref></sup> Sic1 is a specific stoichiometric inhibitor of Cdk1/Clb (CDK/Cyclin in mammalian cells) complexes that are required for S-, G2-, and M-progression and promote spindle pole body separation in yeast.<sup><xref ref-type="bibr" rid="bibr111-1947601912473477">111</xref>,<xref ref-type="bibr" rid="bibr112-1947601912473477">112</xref></sup> Sic1 is synthesized at the end of mitosis and degraded at the beginning of S-phase in a Rpn10-dependent manner.<sup><xref ref-type="bibr" rid="bibr110-1947601912473477">110</xref>,<xref ref-type="bibr" rid="bibr113-1947601912473477">113</xref></sup> During late stages of mitosis, Sic1 inhibits Cdk1/Clb2 activity and is considered to be an activator of M/G1 transition, although the precise mechanisms need to be elucidated.<sup><xref ref-type="bibr" rid="bibr114-1947601912473477">114</xref><xref ref-type="bibr" rid="bibr115-1947601912473477"/><xref ref-type="bibr" rid="bibr116-1947601912473477"/>-<xref ref-type="bibr" rid="bibr117-1947601912473477">117</xref></sup> At the same time, there is some evidence that other ubiquitin receptors, in particular Rad23-Ddi1-Dsk2 proteins (and other UBPs), can share the same function of shuttling targets for degradation with Rpn10, as deletion of Rpn10 in yeast is not lethal and recombinant Rad23 is able to rescue Rpn10 deletion phenotype to some extent. In contrast, deletion of Rpn10 in <italic>Drosophila melanogaster</italic> results in pupal lethality, and siRNA-mediated knockdown of Rpn10 in <italic>Trypanosoma brucei</italic> leads to G2/M cell cycle arrest.<sup><xref ref-type="bibr" rid="bibr91-1947601912473477">91</xref>,<xref ref-type="bibr" rid="bibr118-1947601912473477">118</xref>,<xref ref-type="bibr" rid="bibr119-1947601912473477">119</xref></sup> Thus, the redundancy with other UBPs and the precise role of different domains of Rpn10 remain the unresolved issues that deserve extensive study.</p>
</sec></sec>
<sec id="section14-1947601912473477">
<title>UBPs Regulating Substrates Localization</title>
<sec id="section15-1947601912473477">
<title>p97 complex</title>
<p>Cdc48/p97-Ufd1-Npl4 is the evolutionally conserved protein complex that plays a role in the so-called ERAD (endoplasmic reticulum-associated degradation) pathway. It binds ubiquitinated proteins and is necessary for the export of the misfolded proteins from the ER to the cytoplasm, where they are degraded by the proteasome.<sup><xref ref-type="bibr" rid="bibr120-1947601912473477">120</xref></sup> In this complex, the AAA+ ATPase Cdc48/p97 (also known as VCP in vertebrates) interacts with its adapters Ufd1-Npl4, which are able to bind ubiquitin through their NZF (Npl4 Zn-F) domains.<sup><xref ref-type="bibr" rid="bibr121-1947601912473477">121</xref><xref ref-type="bibr" rid="bibr122-1947601912473477"/>-<xref ref-type="bibr" rid="bibr123-1947601912473477">123</xref></sup> Studies performed in <italic>Xenopus laevis</italic> egg extracts revealed that apart from its function in the ER, the p97 complex regulates spindle disassembly at the end of mitosis and is necessary for formation of a closed nuclear envelope. This occurs through removal of ubiquitinated mitotic kinase Aurora B, a component of the CPC complex, from chromatin by Ufd1-Npl4 adapters during the late stages of mitosis.<sup><xref ref-type="bibr" rid="bibr96-1947601912473477">96</xref></sup> In contrast to this observation, in HeLa cells Ufd1-Npl4 adapters of the p97 complex were shown to antagonize chromosome-associated Aurora B activity already during earlier mitotic stages, which resulted in defects in faithful chromosome segregation as cells progressed through mitotic division.<sup><xref ref-type="bibr" rid="bibr94-1947601912473477">94</xref></sup> These observations are consistent with the model in which Aurora B and possibly other components of CPC are ubiquitinated on the mitotic chromosomes and “extracted” by the action of p97 complex. It is not clear, however, what is the fate of the ubiquitinated Aurora B bound to p97 complex or how this association is regulated. Aurora B kinase is indeed a subject of APC/C-mediated, proteolytic ubiquitination, but this event takes place during later stages of mitotic exit.<sup><xref ref-type="bibr" rid="bibr124-1947601912473477">124</xref></sup> Interestingly, Aurora B was shown to be ubiquitinated earlier during mitosis by Cul3-based E3-ligase, but in contrast to the APC/C-mediated modification, this ubiquitination event does not seem to influence protein stability of Aurora B but rather its faithful relocalization to mitotic spindle.<sup><xref ref-type="bibr" rid="bibr26-1947601912473477">26</xref>,<xref ref-type="bibr" rid="bibr27-1947601912473477">27</xref></sup> It is not clear at this point whether Ufd1-Npl4 adapters localize to the mitotic spindle of whether they may change the affinity of the ubiquitinated CPC toward microtubules. It is necessary to mention that results of another study performed in HeLa cells suggested that Ufd1 rather recruits Aurora B to chromosomes during mitosis.<sup><xref ref-type="bibr" rid="bibr125-1947601912473477">125</xref></sup> Additionally, the authors have identified a putative DUB, USP9x, involved in regulation of dynamics of another CPC component, Survivin protein. Using siRNA, immunostaining, and FRAP techniques, investigators showed that USP9x regulates dissociation of Survivin from the centromeres and thereby chromosome alignment, segregation, and completion of cytokinesis.<sup><xref ref-type="bibr" rid="bibr125-1947601912473477">125</xref></sup> However, the protein levels of Survivin were not affected by downregulation of USP9x. Interestingly, it has been shown that USP9x specifically hydrolyzes both Lys 29 and Lys 33 linked polyubiquitin chains,<sup><xref ref-type="bibr" rid="bibr126-1947601912473477">126</xref></sup> which leads to regulation of activity of AMPK-related kinases and not their proteolysis. It will be interesting to uncover the precise subcellular localization of USP9x in cells during mitotic progression.</p>
<p>Despite evident difficulty in reconciling these observations, it is possible that different CPC components are regulated by several cooperating pathways, involving modification by different ubiquitination signals, proofreading by USP9x deubiquitinating enzyme, and finally dissociation from chromosomes by the action of p97 complex or yet to be identified microtubule-associated UBPs. Intriguingly, several other studies performed in worm <italic>Caenorhabditis elegans</italic> did not show the requirement of p97 complex for mitotic progression.<sup><xref ref-type="bibr" rid="bibr127-1947601912473477">127</xref>,<xref ref-type="bibr" rid="bibr128-1947601912473477">128</xref></sup> Overall, Cdc48/p97-Ufd1-Npl4 complex is considered to play a role in mitosis in vertebrates, but the exact function of ubiquitin-binding adapters Ufd1-Npl4 in this process requires further studies.</p>
</sec></sec>
<sec id="section16-1947601912473477" sec-type="conclusions">
<title>Concluding Remarks and Future Perspectives</title>
<p>Recent progress in study of the ubiquitin pathways has uncovered an enormous versatility and flexibility of this signaling network. This complexity is reflected not only by a plethora of different ubiquitination signals that can be attached to the substrates but also by the fact that their conjugation may take place at a very precise time points during the physiological processes and in a very specific subcellular localizations. This image is further complicated by so-called “decoders” of the ubiquitin signal, which may, on one hand, reverse ubiquitination like DUBs or, on the other hand, transfer the modified substrate to the downstream pathways as in the case of UBPs. For both large family of proteins, at least two functional groups can be distinguished: one that regulates proteasomal degradation (rescue or transfer, respectively) and another that can process the nonproteolytic type of ubiquitination signals and regulates substrate localization, activity, and/or stability of protein complexes (<xref ref-type="fig" rid="fig1-1947601912473477">Fig. 1</xref>). Despite the recent advances in understanding the components of this network in regulation of mitosis, the current list of DUBs and UBPs involved in mitotic progression is far from complete. Thus, identification of new key players in this field will significantly improve our understanding of the principles of mitotic regulation. Likewise, major efforts are needed to understand the precise modes of regulation of these new “decoders,” which could guarantee the essential specificity toward the substrates. We believe that development of imaging technologies, in particular specific “ubiquitin-fluorescent sensors” that could allow visualization of attachment of specific ubiquitin signals in a cellular context, will greatly advance our knowledge about this fascinating signaling network.</p>
</sec>
</body>
<back>
<ack><p>The authors wish to thank the members of the entire Sumara group for careful reading of the manuscript and for helpful discussions.</p></ack>
<fn-group>
<fn fn-type="conflict">
<label>Declaration of Conflicting Interests</label>
<p>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The research in the laboratory of Izabela Sumara is sponsored by IGBMC, ATIP-AVENIR program from CNRS and INSERM, Program de Mecenat from Sanofi-Aventis, Foundation Research Medical (FRM), Region Alsace, and University of Strasbourg.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1947601912473477">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rubin</surname><given-names>DM</given-names></name>
<name><surname>Finley</surname><given-names>D</given-names></name>
</person-group>. <article-title>Proteolysis: the proteasome: a protein-degrading organelle?</article-title> <source>Curr Biol</source>. <year>1995</year>;<volume>5</volume>:<fpage>854</fpage>-<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr2-1947601912473477">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Aguilar</surname><given-names>RC</given-names></name>
<name><surname>Wendland</surname><given-names>B</given-names></name>
</person-group>. <article-title>Ubiquitin: not just for proteasomes anymore</article-title>. <source>Curr Opin Cell Biol</source>. <year>2003</year>;<volume>15</volume>:<fpage>184</fpage>-<lpage>90</lpage>.</citation>
</ref>
<ref id="bibr3-1947601912473477">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Reed</surname><given-names>SI</given-names></name>
</person-group>. <article-title>Ratchets and clocks: the cell cycle, ubiquitylation and protein turnover</article-title>. <source>Nat Rev Mol Cell Biol</source>. <year>2003</year>;<volume>4</volume>:<fpage>855</fpage>-<lpage>64</lpage>.</citation>
</ref>
<ref id="bibr4-1947601912473477">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hershko</surname><given-names>A</given-names></name>
</person-group>. <article-title>The ubiquitin system for protein degradation and some of its roles in the control of the cell division cycle</article-title>. <source>Cell Death Differ</source>. <year>2005</year>;<volume>12</volume>:<fpage>1191</fpage>-<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr5-1947601912473477">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Li</surname><given-names>W</given-names></name>
<name><surname>Ye</surname><given-names>Y</given-names></name>
</person-group>. <article-title>Polyubiquitin chains: functions, structures, and mechanisms</article-title>. <source>Cell Mol Life Sci</source>. <year>2008</year>;<volume>65</volume>:<fpage>2397</fpage>-<lpage>406</lpage>.</citation>
</ref>
<ref id="bibr6-1947601912473477">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Peters</surname><given-names>JM</given-names></name>
</person-group>. <article-title>The anaphase promoting complex/cyclosome: a machine designed to destroy</article-title>. <source>Nat Rev Mol Cell Biol</source>. <year>2006</year>;<volume>7</volume>:<fpage>644</fpage>-<lpage>56</lpage>.</citation>
</ref>
<ref id="bibr7-1947601912473477">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sumara</surname><given-names>I</given-names></name>
<name><surname>Maerki</surname><given-names>S</given-names></name>
<name><surname>Peter</surname><given-names>M</given-names></name>
</person-group>. <article-title>E3 ubiquitin ligases and mitosis: embracing the complexity</article-title>. <source>Trends Cell Biol</source>. <year>2008</year>;<volume>18</volume>:<fpage>84</fpage>-<lpage>94</lpage>.</citation>
</ref>
<ref id="bibr8-1947601912473477">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nakayama</surname><given-names>KI</given-names></name>
<name><surname>Nakayama</surname><given-names>K</given-names></name>
</person-group>. <article-title>Ubiquitin ligases: cell-cycle control and cancer</article-title>. <source>Nat Rev Cancer</source>. <year>2006</year>;<volume>6</volume>:<fpage>369</fpage>-<lpage>81</lpage>.</citation>
</ref>
<ref id="bibr9-1947601912473477">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tyers</surname><given-names>M</given-names></name>
<name><surname>Jorgensen</surname><given-names>P</given-names></name>
</person-group>. <article-title>Proteolysis and the cell cycle: with this RING I do thee destroy</article-title>. <source>Curr Opin Genet Dev</source>. <year>2000</year>;<volume>10</volume>:<fpage>54</fpage>-<lpage>64</lpage>.</citation>
</ref>
<ref id="bibr10-1947601912473477">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ang</surname><given-names>XL</given-names></name>
<name><surname>Harper</surname><given-names>JW</given-names></name>
</person-group>. <article-title>Interwoven ubiquitination oscillators and control of cell cycle transitions</article-title>. <source>Sci STKE</source>. <year>2004</year>;<volume>2004</volume>:<fpage>pe31</fpage>.</citation>
</ref>
<ref id="bibr11-1947601912473477">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Al-Hakim</surname><given-names>A</given-names></name>
<name><surname>Escribano-Diaz</surname><given-names>C</given-names></name>
<name><surname>Landry</surname><given-names>MC</given-names></name>
<etal/></person-group>. <article-title>The ubiquitous role of ubiquitin in the DNA damage response</article-title>. <source>DNA Repair (Amst)</source>. <year>2010</year>;<volume>9</volume>:<fpage>1229</fpage>-<lpage>40</lpage>.</citation>
</ref>
<ref id="bibr12-1947601912473477">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hannah</surname><given-names>J</given-names></name>
<name><surname>Zhou</surname><given-names>P</given-names></name>
</person-group>. <article-title>Regulation of DNA damage response pathways by the cullin-RING ubiquitin ligases</article-title>. <source>DNA Repair (Amst)</source>. <year>2009</year>;<volume>8</volume>:<fpage>536</fpage>-<lpage>43</lpage>.</citation>
</ref>
<ref id="bibr13-1947601912473477">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ulrich</surname><given-names>HD</given-names></name>
</person-group>. <article-title>Timing and spacing of ubiquitin-dependent DNA damage bypass</article-title>. <source>FEBS Lett</source>. <year>2011</year>;<volume>585</volume>:<fpage>2861</fpage>-<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr14-1947601912473477">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lengauer</surname><given-names>C</given-names></name>
<name><surname>Kinzler</surname><given-names>KW</given-names></name>
<name><surname>Vogelstein</surname><given-names>B</given-names></name>
</person-group>. <article-title>Genetic instabilities in human cancers</article-title>. <source>Nature</source>. <year>1998</year>;<volume>396</volume>:<fpage>643</fpage>-<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr15-1947601912473477">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kadura</surname><given-names>S</given-names></name>
<name><surname>Sazer</surname><given-names>S</given-names></name>
</person-group>. <article-title>SAC-ing mitotic errors: how the spindle assembly checkpoint (SAC) plays defense against chromosome mis-segregation</article-title>. <source>Cell Motil Cytoskeleton</source>. <year>2005</year>;<volume>61</volume>:<fpage>145</fpage>-<lpage>60</lpage>.</citation>
</ref>
<ref id="bibr16-1947601912473477">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lew</surname><given-names>DJ</given-names></name>
<name><surname>Burke</surname><given-names>DJ</given-names></name>
</person-group>. <article-title>The spindle assembly and spindle position checkpoints</article-title>. <source>Annu Rev Genet</source>. <year>2003</year>;<volume>37</volume>:<fpage>251</fpage>-<lpage>82</lpage>.</citation>
</ref>
<ref id="bibr17-1947601912473477">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tan</surname><given-names>AL</given-names></name>
<name><surname>Rida</surname><given-names>PC</given-names></name>
<name><surname>Surana</surname><given-names>U</given-names></name>
</person-group>. <article-title>Essential tension and constructive destruction: the spindle checkpoint and its regulatory links with mitotic exit</article-title>. <source>Biochem J</source>. <year>2005</year>;<volume>386</volume>:<fpage>1</fpage>-<lpage>13</lpage>.</citation>
</ref>
<ref id="bibr18-1947601912473477">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Musacchio</surname><given-names>A</given-names></name>
<name><surname>Salmon</surname><given-names>ED</given-names></name>
</person-group>. <article-title>The spindle-assembly checkpoint in space and time</article-title>. <source>Nat Rev Mol Cell Biol</source>. <year>2007</year>;<volume>8</volume>:<fpage>379</fpage>-<lpage>93</lpage>.</citation>
</ref>
<ref id="bibr19-1947601912473477">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Glotzer</surname><given-names>M</given-names></name>
</person-group>. <article-title>The molecular requirements for cytokinesis</article-title>. <source>Science</source>. <year>2005</year>;<volume>307</volume>:<fpage>1735</fpage>-<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr20-1947601912473477">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Guertin</surname><given-names>DA</given-names></name>
<name><surname>Trautmann</surname><given-names>S</given-names></name>
<name><surname>McCollum</surname><given-names>D</given-names></name>
</person-group>. <article-title>Cytokinesis in eukaryotes</article-title>. <source>Microbiol Mol Biol Rev</source>. <year>2002</year>;<volume>66</volume>:<fpage>155</fpage>-<lpage>78</lpage>.</citation>
</ref>
<ref id="bibr21-1947601912473477">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McCollum</surname><given-names>D</given-names></name>
</person-group>. <article-title>Cytokinesis: the central spindle takes center stage</article-title>. <source>Curr Biol</source>. <year>2004</year>;<volume>14</volume>:<fpage>R953</fpage>-<lpage>5</lpage>.</citation>
</ref>
<ref id="bibr22-1947601912473477">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Glotzer</surname><given-names>M</given-names></name>
</person-group>. <article-title>Animal cell cytokinesis</article-title>. <source>Annu Rev Cell Dev Biol</source>. <year>2001</year>;<volume>17</volume>:<fpage>351</fpage>-<lpage>86</lpage>.</citation>
</ref>
<ref id="bibr23-1947601912473477">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Meraldi</surname><given-names>P</given-names></name>
<name><surname>Draviam</surname><given-names>VM</given-names></name>
<name><surname>Sorger</surname><given-names>PK</given-names></name>
</person-group>. <article-title>Timing and checkpoints in the regulation of mitotic progression</article-title>. <source>Dev Cell</source>. <year>2004</year>;<volume>7</volume>:<fpage>45</fpage>-<lpage>60</lpage>.</citation>
</ref>
<ref id="bibr24-1947601912473477">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Norden</surname><given-names>C</given-names></name>
<name><surname>Mendoza</surname><given-names>M</given-names></name>
<name><surname>Dobbelaere</surname><given-names>J</given-names></name>
<name><surname>Kotwaliwale</surname><given-names>CV</given-names></name>
<name><surname>Biggins</surname><given-names>S</given-names></name>
<name><surname>Barral</surname><given-names>Y</given-names></name>
</person-group>. <article-title>The NoCut pathway links completion of cytokinesis to spindle midzone function to prevent chromosome breakage</article-title>. <source>Cell</source>. <year>2006</year>;<volume>125</volume>:<fpage>85</fpage>-<lpage>98</lpage>.</citation>
</ref>
<ref id="bibr25-1947601912473477">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vodermaier</surname><given-names>HC</given-names></name>
</person-group>. <article-title>APC/C and SCF: controlling each other and the cell cycle</article-title>. <source>Curr Biol</source>. <year>2004</year>;<volume>14</volume>:<fpage>R787</fpage>-<lpage>96</lpage>.</citation>
</ref>
<ref id="bibr26-1947601912473477">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sumara</surname><given-names>I</given-names></name>
<name><surname>Quadroni</surname><given-names>M</given-names></name>
<name><surname>Frei</surname><given-names>C</given-names></name>
<etal/></person-group>. <article-title>A Cul3-based E3 ligase removes Aurora B from mitotic chromosomes, regulating mitotic progression and completion of cytokinesis in human cells</article-title>. <source>Dev Cell</source>. <year>2007</year>;<volume>12</volume>:<fpage>887</fpage>-<lpage>900</lpage>.</citation>
</ref>
<ref id="bibr27-1947601912473477">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Maerki</surname><given-names>S</given-names></name>
<name><surname>Olma</surname><given-names>MH</given-names></name>
<name><surname>Staubli</surname><given-names>T</given-names></name>
<etal/></person-group>. <article-title>The Cul3-KLHL21 E3 ubiquitin ligase targets aurora B to midzone microtubules in anaphase and is required for cytokinesis</article-title>. <source>J Cell Biol</source>. <year>2009</year>;<volume>187</volume>:<fpage>791</fpage>-<lpage>800</lpage>.</citation>
</ref>
<ref id="bibr28-1947601912473477">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Komander</surname><given-names>D</given-names></name>
<name><surname>Clague</surname><given-names>MJ</given-names></name>
<name><surname>Urbe</surname><given-names>S</given-names></name>
</person-group>. <article-title>Breaking the chains: structure and function of the deubiquitinases</article-title>. <source>Nat Rev Mol Cell Biol</source>. <year>2009</year>;<volume>10</volume>:<fpage>550</fpage>-<lpage>63</lpage>.</citation>
</ref>
<ref id="bibr29-1947601912473477">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nijman</surname><given-names>SM</given-names></name>
<name><surname>Luna-Vargas</surname><given-names>MP</given-names></name>
<name><surname>Velds</surname><given-names>A</given-names></name>
<etal/></person-group>. <article-title>A genomic and functional inventory of deubiquitinating enzymes</article-title>. <source>Cell</source>. <year>2005</year>;<volume>123</volume>:<fpage>773</fpage>-<lpage>86</lpage>.</citation>
</ref>
<ref id="bibr30-1947601912473477">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Reyes-Turcu</surname><given-names>FE</given-names></name>
<name><surname>Ventii</surname><given-names>KH</given-names></name>
<name><surname>Wilkinson</surname><given-names>KD</given-names></name>
</person-group>. <article-title>Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes</article-title>. <source>Annu Rev Biochem</source>. <year>2009</year>;<volume>78</volume>:<fpage>363</fpage>-<lpage>97</lpage>.</citation>
</ref>
<ref id="bibr31-1947601912473477">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hay</surname><given-names>RT</given-names></name>
</person-group>. <article-title>SUMO-specific proteases: a twist in the tail</article-title>. <source>Trends Cell Biol</source>. <year>2007</year>;<volume>17</volume>:<fpage>370</fpage>-<lpage>6</lpage>.</citation>
</ref>
<ref id="bibr32-1947601912473477">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>W</given-names></name>
<name><surname>Bennett</surname><given-names>EJ</given-names></name>
<name><surname>Huttlin</surname><given-names>EL</given-names></name>
<etal/></person-group>. <article-title>Systematic and quantitative assessment of the ubiquitin-modified proteome</article-title>. <source>Mol Cell</source>. <year>2011</year>;<volume>44</volume>:<fpage>325</fpage>-<lpage>40</lpage>.</citation>
</ref>
<ref id="bibr33-1947601912473477">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hwang</surname><given-names>LH</given-names></name>
<name><surname>Lau</surname><given-names>LF</given-names></name>
<name><surname>Smith</surname><given-names>DL</given-names></name>
<etal/></person-group>. <article-title>Budding yeast Cdc20: a target of the spindle checkpoint</article-title>. <source>Science</source>. <year>1998</year>;<volume>279</volume>:<fpage>1041</fpage>-<lpage>4</lpage>.</citation>
</ref>
<ref id="bibr34-1947601912473477">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>SH</given-names></name>
<name><surname>Lin</surname><given-names>DP</given-names></name>
<name><surname>Matsumoto</surname><given-names>S</given-names></name>
<name><surname>Kitazono</surname><given-names>A</given-names></name>
<name><surname>Matsumoto</surname><given-names>T</given-names></name>
</person-group>. <article-title>Fission yeast Slp1: an effector of the Mad2-dependent spindle checkpoint</article-title>. <source>Science</source>. <year>1998</year>;<volume>279</volume>:<fpage>1045</fpage>-<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr35-1947601912473477">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sudakin</surname><given-names>V</given-names></name>
<name><surname>Chan</surname><given-names>GK</given-names></name>
<name><surname>Yen</surname><given-names>TJ</given-names></name>
</person-group>. <article-title>Checkpoint inhibition of the APC/C in HeLa cells is mediated by a complex of BUBR1, BUB3, CDC20, and MAD2</article-title>. <source>J Cell Biol</source>. <year>2001</year>;<volume>154</volume>:<fpage>925</fpage>-<lpage>36</lpage>.</citation>
</ref>
<ref id="bibr36-1947601912473477">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stegmeier</surname><given-names>F</given-names></name>
<name><surname>Rape</surname><given-names>M</given-names></name>
<name><surname>Draviam</surname><given-names>VM</given-names></name>
<etal/></person-group>. <article-title>Anaphase initiation is regulated by antagonistic ubiquitination and deubiquitination activities</article-title>. <source>Nature</source>. <year>2007</year>;<volume>446</volume>:<fpage>876</fpage>-<lpage>81</lpage>.</citation>
</ref>
<ref id="bibr37-1947601912473477">
<label>37.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Reddy</surname><given-names>SK</given-names></name>
<name><surname>Rape</surname><given-names>M</given-names></name>
<name><surname>Margansky</surname><given-names>WA</given-names></name>
<name><surname>Kirschner</surname><given-names>MW</given-names></name>
</person-group>. <article-title>Ubiquitination by the anaphase-promoting complex drives spindle checkpoint inactivation</article-title>. <source>Nature</source>. <year>2007</year>;<volume>446</volume>:<fpage>921</fpage>-<lpage>5</lpage>.</citation>
</ref>
<ref id="bibr38-1947601912473477">
<label>38.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Visconti</surname><given-names>R</given-names></name>
<name><surname>Palazzo</surname><given-names>L</given-names></name>
<name><surname>Della Monica</surname><given-names>R</given-names></name>
<name><surname>Grieco</surname><given-names>D</given-names></name>
</person-group>. <article-title>Fcp1-dependent dephosphorylation is required for M-phase-promoting factor inactivation at mitosis exit</article-title>. <source>Nat Commun</source>. <year>2012</year>;<volume>3</volume>:<fpage>894</fpage>.</citation>
</ref>
<ref id="bibr39-1947601912473477">
<label>39.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Son</surname><given-names>S</given-names></name>
<name><surname>Osmani</surname><given-names>SA</given-names></name>
</person-group>. <article-title>Analysis of all protein phosphatase genes in Aspergillus nidulans identifies a new mitotic regulator, fcp1</article-title>. <source>Eukaryot Cell</source>. <year>2009</year>;<volume>8</volume>:<fpage>573</fpage>-<lpage>85</lpage>.</citation>
</ref>
<ref id="bibr40-1947601912473477">
<label>40.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nilsson</surname><given-names>J</given-names></name>
<name><surname>Yekezare</surname><given-names>M</given-names></name>
<name><surname>Minshull</surname><given-names>J</given-names></name>
<name><surname>Pines</surname><given-names>J</given-names></name>
</person-group>. <article-title>The APC/C maintains the spindle assembly checkpoint by targeting Cdc20 for destruction</article-title>. <source>Nat Cell Biol</source>. <year>2008</year>;<volume>10</volume>:<fpage>1411</fpage>-<lpage>20</lpage>.</citation>
</ref>
<ref id="bibr41-1947601912473477">
<label>41.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pan</surname><given-names>J</given-names></name>
<name><surname>Chen</surname><given-names>RH</given-names></name>
</person-group>. <article-title>Spindle checkpoint regulates Cdc20p stability in Saccharomyces cerevisiae</article-title>. <source>Genes Dev</source>. <year>2004</year>;<volume>18</volume>:<fpage>1439</fpage>-<lpage>51</lpage>.</citation>
</ref>
<ref id="bibr42-1947601912473477">
<label>42.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>Y</given-names></name>
<name><surname>van Deursen</surname><given-names>J</given-names></name>
<name><surname>Galardy</surname><given-names>PJ</given-names></name>
</person-group>. <article-title>Overexpression of ubiquitin specific protease 44 (USP44) induces chromosomal instability and is frequently observed in human T-cell leukemia</article-title>. <source>PLoS One</source>. <year>2011</year>;<volume>6</volume>:<fpage>e23389</fpage>.</citation>
</ref>
<ref id="bibr43-1947601912473477">
<label>43.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stegmeier</surname><given-names>F</given-names></name>
<name><surname>Sowa</surname><given-names>ME</given-names></name>
<name><surname>Nalepa</surname><given-names>G</given-names></name>
<name><surname>Gygi</surname><given-names>SP</given-names></name>
<name><surname>Harper</surname><given-names>JW</given-names></name>
<name><surname>Elledge</surname><given-names>SJ</given-names></name>
</person-group>. <article-title>The tumor suppressor CYLD regulates entry into mitosis</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2007</year>;<volume>104</volume>:<fpage>8869</fpage>-<lpage>74</lpage>.</citation>
</ref>
<ref id="bibr44-1947601912473477">
<label>44.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bignell</surname><given-names>GR</given-names></name>
<name><surname>Warren</surname><given-names>W</given-names></name>
<name><surname>Seal</surname><given-names>S</given-names></name>
<etal/></person-group>. <article-title>Identification of the familial cylindromatosis tumour-suppressor gene</article-title>. <source>Nat Genet</source>. <year>2000</year>;<volume>25</volume>:<fpage>160</fpage>-<lpage>5</lpage>.</citation>
</ref>
<ref id="bibr45-1947601912473477">
<label>45.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Brummelkamp</surname><given-names>TR</given-names></name>
<name><surname>Nijman</surname><given-names>SM</given-names></name>
<name><surname>Dirac</surname><given-names>AM</given-names></name>
<name><surname>Bernards</surname><given-names>R</given-names></name>
</person-group>. <article-title>Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB</article-title>. <source>Nature</source>. <year>2003</year>;<volume>424</volume>:<fpage>797</fpage>-<lpage>801</lpage>.</citation>
</ref>
<ref id="bibr46-1947601912473477">
<label>46.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kovalenko</surname><given-names>A</given-names></name>
<name><surname>Chable-Bessia</surname><given-names>C</given-names></name>
<name><surname>Cantarella</surname><given-names>G</given-names></name>
<name><surname>Israel</surname><given-names>A</given-names></name>
<name><surname>Wallach</surname><given-names>D</given-names></name>
<name><surname>Courtois</surname><given-names>G</given-names></name>
</person-group>. <article-title>The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination</article-title>. <source>Nature</source>. <year>2003</year>;<volume>424</volume>:<fpage>801</fpage>-<lpage>5</lpage>.</citation>
</ref>
<ref id="bibr47-1947601912473477">
<label>47.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Trompouki</surname><given-names>E</given-names></name>
<name><surname>Hatzivassiliou</surname><given-names>E</given-names></name>
<name><surname>Tsichritzis</surname><given-names>T</given-names></name>
<name><surname>Farmer</surname><given-names>H</given-names></name>
<name><surname>Ashworth</surname><given-names>A</given-names></name>
<name><surname>Mosialos</surname><given-names>G</given-names></name>
</person-group>. <article-title>CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members</article-title>. <source>Nature</source>. <year>2003</year>;<volume>424</volume>:<fpage>793</fpage>-<lpage>6</lpage>.</citation>
</ref>
<ref id="bibr48-1947601912473477">
<label>48.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tauriello</surname><given-names>DV</given-names></name>
<name><surname>Haegebarth</surname><given-names>A</given-names></name>
<name><surname>Kuper</surname><given-names>I</given-names></name>
<etal/></person-group>. <article-title>Loss of the tumor suppressor CYLD enhances Wnt/beta-catenin signaling through K63-linked ubiquitination of Dvl</article-title>. <source>Mol Cell</source>. <year>2010</year>;<volume>37</volume>:<fpage>607</fpage>-<lpage>19</lpage>.</citation>
</ref>
<ref id="bibr49-1947601912473477">
<label>49.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Komander</surname><given-names>D</given-names></name>
<name><surname>Reyes-Turcu</surname><given-names>F</given-names></name>
<name><surname>Licchesi</surname><given-names>JD</given-names></name>
<name><surname>Odenwaelder</surname><given-names>P</given-names></name>
<name><surname>Wilkinson</surname><given-names>KD</given-names></name>
<name><surname>Barford</surname><given-names>D</given-names></name>
</person-group>. <article-title>Molecular discrimination of structurally equivalent Lys 63-linked and linear polyubiquitin chains</article-title>. <source>EMBO Rep</source>. <year>2009</year>;<volume>10</volume>:<fpage>466</fpage>-<lpage>73</lpage>.</citation>
</ref>
<ref id="bibr50-1947601912473477">
<label>50.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Qian</surname><given-names>YW</given-names></name>
<name><surname>Erikson</surname><given-names>E</given-names></name>
<name><surname>Taieb</surname><given-names>FE</given-names></name>
<name><surname>Maller</surname><given-names>JL</given-names></name>
</person-group>. <article-title>The polo-like kinase Plx1 is required for activation of the phosphatase Cdc25C and cyclin B-Cdc2 in Xenopus oocytes</article-title>. <source>Mol Biol Cell</source>. <year>2001</year>;<volume>12</volume>:<fpage>1791</fpage>-<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr51-1947601912473477">
<label>51.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cogswell</surname><given-names>JP</given-names></name>
<name><surname>Brown</surname><given-names>CE</given-names></name>
<name><surname>Bisi</surname><given-names>JE</given-names></name>
<name><surname>Neill</surname><given-names>SD</given-names></name>
</person-group>. <article-title>Dominant-negative polo-like kinase 1 induces mitotic catastrophe independent of cdc25C function</article-title>. <source>Cell Growth Differ</source>. <year>2000</year>;<volume>11</volume>:<fpage>615</fpage>-<lpage>23</lpage>.</citation>
</ref>
<ref id="bibr52-1947601912473477">
<label>52.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sumara</surname><given-names>I</given-names></name>
<name><surname>Gimenez-Abian</surname><given-names>JF</given-names></name>
<name><surname>Gerlich</surname><given-names>D</given-names></name>
<etal/></person-group>. <article-title>Roles of polo-like kinase 1 in the assembly of functional mitotic spindles</article-title>. <source>Curr Biol</source>. <year>2004</year>;<volume>14</volume>:<fpage>1712</fpage>-<lpage>22</lpage>.</citation>
</ref>
<ref id="bibr53-1947601912473477">
<label>53.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Scolnick</surname><given-names>DM</given-names></name>
<name><surname>Halazonetis</surname><given-names>TD</given-names></name>
</person-group>. <article-title>Chfr defines a mitotic stress checkpoint that delays entry into metaphase</article-title>. <source>Nature</source>. <year>2000</year>;<volume>406</volume>:<fpage>430</fpage>-<lpage>5</lpage>.</citation>
</ref>
<ref id="bibr54-1947601912473477">
<label>54.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kang</surname><given-names>D</given-names></name>
<name><surname>Chen</surname><given-names>J</given-names></name>
<name><surname>Wong</surname><given-names>J</given-names></name>
<name><surname>Fang</surname><given-names>G</given-names></name>
</person-group>. <article-title>The checkpoint protein Chfr is a ligase that ubiquitinates Plk1 and inhibits Cdc2 at the G2 to M transition</article-title>. <source>J Cell Biol</source>. <year>2002</year>;<volume>156</volume>:<fpage>249</fpage>-<lpage>59</lpage>.</citation>
</ref>
<ref id="bibr55-1947601912473477">
<label>55.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chaturvedi</surname><given-names>P</given-names></name>
<name><surname>Sudakin</surname><given-names>V</given-names></name>
<name><surname>Bobiak</surname><given-names>ML</given-names></name>
<etal/></person-group>. <article-title>Chfr regulates a mitotic stress pathway through its RING-finger domain with ubiquitin ligase activity</article-title>. <source>Cancer Res</source>. <year>2002</year>;<volume>62</volume>:<fpage>1797</fpage>-<lpage>801</lpage>.</citation>
</ref>
<ref id="bibr56-1947601912473477">
<label>56.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bothos</surname><given-names>J</given-names></name>
<name><surname>Summers</surname><given-names>MK</given-names></name>
<name><surname>Venere</surname><given-names>M</given-names></name>
<name><surname>Scolnick</surname><given-names>DM</given-names></name>
<name><surname>Halazonetis</surname><given-names>TD</given-names></name>
</person-group>. <article-title>The Chfr mitotic checkpoint protein functions with Ubc13-Mms2 to form Lys63-linked polyubiquitin chains</article-title>. <source>Oncogene</source>. <year>2003</year>;<volume>22</volume>:<fpage>7101</fpage>-<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr57-1947601912473477">
<label>57.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gao</surname><given-names>J</given-names></name>
<name><surname>Huo</surname><given-names>L</given-names></name>
<name><surname>Sun</surname><given-names>X</given-names></name>
<etal/></person-group>. <article-title>The tumor suppressor CYLD regulates microtubule dynamics and plays a role in cell migration</article-title>. <source>J Biol Chem</source>. <year>2008</year>;<volume>283</volume>:<fpage>8802</fpage>-<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr58-1947601912473477">
<label>58.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wickstrom</surname><given-names>SA</given-names></name>
<name><surname>Masoumi</surname><given-names>KC</given-names></name>
<name><surname>Khochbin</surname><given-names>S</given-names></name>
<name><surname>Fassler</surname><given-names>R</given-names></name>
<name><surname>Massoumi</surname><given-names>R</given-names></name>
</person-group>. <article-title>CYLD negatively regulates cell-cycle progression by inactivating HDAC6 and increasing the levels of acetylated tubulin</article-title>. <source>EMBO J</source>. <year>2010</year>;<volume>29</volume>:<fpage>131</fpage>-<lpage>44</lpage>.</citation>
</ref>
<ref id="bibr59-1947601912473477">
<label>59.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gomez-Ferreria</surname><given-names>MA</given-names></name>
<name><surname>Bashkurov</surname><given-names>M</given-names></name>
<name><surname>Mullin</surname><given-names>M</given-names></name>
<name><surname>Gingras</surname><given-names>AC</given-names></name>
<name><surname>Pelletier</surname><given-names>L</given-names></name>
</person-group>. <article-title>CEP192 interacts physically and functionally with the K63-deubiquitinase CYLD to promote mitotic spindle assembly</article-title>. <source>Cell Cycle</source>. <year>2012</year>;<volume>11</volume>:<fpage>3555</fpage>-<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr60-1947601912473477">
<label>60.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zhu</surname><given-names>F</given-names></name>
<name><surname>Lawo</surname><given-names>S</given-names></name>
<name><surname>Bird</surname><given-names>A</given-names></name>
<etal/></person-group>. <article-title>The mammalian SPD-2 ortholog Cep192 regulates centrosome biogenesis</article-title>. <source>Curr Biol</source>. <year>2008</year>;<volume>18</volume>:<fpage>136</fpage>-<lpage>41</lpage>.</citation>
</ref>
<ref id="bibr61-1947601912473477">
<label>61.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gomez-Ferreria</surname><given-names>MA</given-names></name>
<name><surname>Rath</surname><given-names>U</given-names></name>
<name><surname>Buster</surname><given-names>DW</given-names></name>
<etal/></person-group>. <article-title>Human Cep192 is required for mitotic centrosome and spindle assembly</article-title>. <source>Curr Biol</source>. <year>2007</year>;<volume>17</volume>:<fpage>1960</fpage>-<lpage>6</lpage>.</citation>
</ref>
<ref id="bibr62-1947601912473477">
<label>62.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>van Leuken</surname><given-names>RJ</given-names></name>
<name><surname>Luna-Vargas</surname><given-names>MP</given-names></name>
<name><surname>Sixma</surname><given-names>TK</given-names></name>
<name><surname>Wolthuis</surname><given-names>RM</given-names></name>
<name><surname>Medema</surname><given-names>RH</given-names></name>
</person-group>. <article-title>Usp39 is essential for mitotic spindle checkpoint integrity and controls mRNA-levels of aurora B</article-title>. <source>Cell Cycle</source>. <year>2008</year>;<volume>7</volume>:<fpage>2710</fpage>-<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr63-1947601912473477">
<label>63.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Makarova</surname><given-names>OV</given-names></name>
<name><surname>Makarov</surname><given-names>EM</given-names></name>
<name><surname>Luhrmann</surname><given-names>R</given-names></name>
</person-group>. <article-title>The 65 and 110 kDa SR-related proteins of the U4/U6.U5 tri-snRNP are essential for the assembly of mature spliceosomes</article-title>. <source>EMBO J</source>. <year>2001</year>;<volume>20</volume>:<fpage>2553</fpage>-<lpage>63</lpage>.</citation>
</ref>
<ref id="bibr64-1947601912473477">
<label>64.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hauf</surname><given-names>S</given-names></name>
<name><surname>Cole</surname><given-names>RW</given-names></name>
<name><surname>LaTerra</surname><given-names>S</given-names></name>
<etal/></person-group>. <article-title>The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint</article-title>. <source>J Cell Biol</source>. <year>2003</year>;<volume>161</volume>:<fpage>281</fpage>-<lpage>94</lpage>.</citation>
</ref>
<ref id="bibr65-1947601912473477">
<label>65.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tanaka</surname><given-names>TU</given-names></name>
<name><surname>Rachidi</surname><given-names>N</given-names></name>
<name><surname>Janke</surname><given-names>C</given-names></name>
<etal/></person-group>. <article-title>Evidence that the Ipl1-Sli15 (Aurora kinase-INCENP) complex promotes chromosome bi-orientation by altering kinetochore-spindle pole connections</article-title>. <source>Cell</source>. <year>2002</year>;<volume>108</volume>:<fpage>317</fpage>-<lpage>29</lpage>.</citation>
</ref>
<ref id="bibr66-1947601912473477">
<label>66.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lampson</surname><given-names>MA</given-names></name>
<name><surname>Renduchitala</surname><given-names>K</given-names></name>
<name><surname>Khodjakov</surname><given-names>A</given-names></name>
<name><surname>Kapoor</surname><given-names>TM</given-names></name>
</person-group>. <article-title>Correcting improper chromosome-spindle attachments during cell division</article-title>. <source>Nat Cell Biol</source>. <year>2004</year>;<volume>6</volume>:<fpage>232</fpage>-<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr67-1947601912473477">
<label>67.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nakada</surname><given-names>S</given-names></name>
<name><surname>Tai</surname><given-names>I</given-names></name>
<name><surname>Panier</surname><given-names>S</given-names></name>
<etal/></person-group>. <article-title>Non-canonical inhibition of DNA damage-dependent ubiquitination by OTUB1</article-title>. <source>Nature</source>. <year>2010</year>;<volume>466</volume>:<fpage>941</fpage>-<lpage>6</lpage>.</citation>
</ref>
<ref id="bibr68-1947601912473477">
<label>68.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hanna</surname><given-names>J</given-names></name>
<name><surname>Hathaway</surname><given-names>NA</given-names></name>
<name><surname>Tone</surname><given-names>Y</given-names></name>
<etal/></person-group>. <article-title>Deubiquitinating enzyme Ubp6 functions noncatalytically to delay proteasomal degradation</article-title>. <source>Cell</source>. <year>2006</year>;<volume>127</volume>:<fpage>99</fpage>-<lpage>111</lpage>.</citation>
</ref>
<ref id="bibr69-1947601912473477">
<label>69.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Quesada</surname><given-names>V</given-names></name>
<name><surname>Diaz-Perales</surname><given-names>A</given-names></name>
<name><surname>Gutierrez-Fernandez</surname><given-names>A</given-names></name>
<name><surname>Garabaya</surname><given-names>C</given-names></name>
<name><surname>Cal</surname><given-names>S</given-names></name>
<name><surname>Lopez-Otin</surname><given-names>C</given-names></name>
</person-group>. <article-title>Cloning and enzymatic analysis of 22 novel human ubiquitin-specific proteases</article-title>. <source>Biochem Biophys Res Commun</source>. <year>2004</year>;<volume>314</volume>:<fpage>54</fpage>-<lpage>62</lpage>.</citation>
</ref>
<ref id="bibr70-1947601912473477">
<label>70.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Song</surname><given-names>EJ</given-names></name>
<name><surname>Werner</surname><given-names>SL</given-names></name>
<name><surname>Neubauer</surname><given-names>J</given-names></name>
<etal/></person-group>. <article-title>The Prp19 complex and the Usp4Sart3 deubiquitinating enzyme control reversible ubiquitination at the spliceosome</article-title>. <source>Genes Dev</source>. <year>2010</year>;<volume>24</volume>:<fpage>1434</fpage>-<lpage>47</lpage>.</citation>
</ref>
<ref id="bibr71-1947601912473477">
<label>71.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wahl</surname><given-names>MC</given-names></name>
<name><surname>Will</surname><given-names>CL</given-names></name>
<name><surname>Luhrmann</surname><given-names>R</given-names></name>
</person-group>. <article-title>The spliceosome: design principles of a dynamic RNP machine</article-title>. <source>Cell</source>. <year>2009</year>;<volume>136</volume>:<fpage>701</fpage>-<lpage>18</lpage>.</citation>
</ref>
<ref id="bibr72-1947601912473477">
<label>72.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chen</surname><given-names>CH</given-names></name>
<name><surname>Kao</surname><given-names>DI</given-names></name>
<name><surname>Chan</surname><given-names>SP</given-names></name>
<name><surname>Kao</surname><given-names>TC</given-names></name>
<name><surname>Lin</surname><given-names>JY</given-names></name>
<name><surname>Cheng</surname><given-names>SC</given-names></name>
</person-group>. <article-title>Functional links between the Prp19-associated complex, U4/U6 biogenesis, and spliceosome recycling</article-title>. <source>RNA</source>. <year>2006</year>;<volume>12</volume>:<fpage>765</fpage>-<lpage>74</lpage>.</citation>
</ref>
<ref id="bibr73-1947601912473477">
<label>73.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chan</surname><given-names>SP</given-names></name>
<name><surname>Kao</surname><given-names>DI</given-names></name>
<name><surname>Tsai</surname><given-names>WY</given-names></name>
<name><surname>Cheng</surname><given-names>SC</given-names></name>
</person-group>. <article-title>The Prp19p-associated complex in spliceosome activation</article-title>. <source>Science</source>. <year>2003</year>;<volume>302</volume>:<fpage>279</fpage>-<lpage>82</lpage>.</citation>
</ref>
<ref id="bibr74-1947601912473477">
<label>74.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bellare</surname><given-names>P</given-names></name>
<name><surname>Kutach</surname><given-names>AK</given-names></name>
<name><surname>Rines</surname><given-names>AK</given-names></name>
<name><surname>Guthrie</surname><given-names>C</given-names></name>
<name><surname>Sontheimer</surname><given-names>EJ</given-names></name>
</person-group>. <article-title>Ubiquitin binding by a variant Jab1/MPN domain in the essential pre-mRNA splicing factor Prp8p</article-title>. <source>RNA</source>. <year>2006</year>;<volume>12</volume>:<fpage>292</fpage>-<lpage>302</lpage>.</citation>
</ref>
<ref id="bibr75-1947601912473477">
<label>75.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bellare</surname><given-names>P</given-names></name>
<name><surname>Small</surname><given-names>EC</given-names></name>
<name><surname>Huang</surname><given-names>X</given-names></name>
<name><surname>Wohlschlegel</surname><given-names>JA</given-names></name>
<name><surname>Staley</surname><given-names>JP</given-names></name>
<name><surname>Sontheimer</surname><given-names>EJ</given-names></name>
</person-group>. <article-title>A role for ubiquitin in the spliceosome assembly pathway</article-title>. <source>Nat Struct Mol Biol</source>. <year>2008</year>;<volume>15</volume>:<fpage>444</fpage>-<lpage>51</lpage>.</citation>
</ref>
<ref id="bibr76-1947601912473477">
<label>76.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Frederick</surname><given-names>A</given-names></name>
<name><surname>Rolfe</surname><given-names>M</given-names></name>
<name><surname>Chiu</surname><given-names>MI</given-names></name>
</person-group>. <article-title>The human UNP locus at 3p21.31 encodes two tissue-selective, cytoplasmic isoforms with deubiquitinating activity that have reduced expression in small cell lung carcinoma cell lines</article-title>. <source>Oncogene</source>. <year>1998</year>;<volume>16</volume>:<fpage>153</fpage>-<lpage>65</lpage>.</citation>
</ref>
<ref id="bibr77-1947601912473477">
<label>77.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hann</surname><given-names>CL</given-names></name>
<name><surname>Rudin</surname><given-names>CM</given-names></name>
</person-group>. <article-title>Fast, hungry and unstable: finding the Achilles’ heel of small-cell lung cancer</article-title>. <source>Trends Mol Med</source>. <year>2007</year>;<volume>13</volume>:<fpage>150</fpage>-<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr78-1947601912473477">
<label>78.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rape</surname><given-names>M</given-names></name>
<name><surname>Reddy</surname><given-names>SK</given-names></name>
<name><surname>Kirschner</surname><given-names>MW</given-names></name>
</person-group>. <article-title>The processivity of multiubiquitination by the APC determines the order of substrate degradation</article-title>. <source>Cell</source>. <year>2006</year>;<volume>124</volume>:<fpage>89</fpage>-<lpage>103</lpage>.</citation>
</ref>
<ref id="bibr79-1947601912473477">
<label>79.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Huang</surname><given-names>X</given-names></name>
<name><surname>Summers</surname><given-names>MK</given-names></name>
<name><surname>Pham</surname><given-names>V</given-names></name>
<etal/></person-group>. <article-title>Deubiquitinase USP37 is activated by CDK2 to antagonize APC(CDH1) and promote S phase entry</article-title>. <source>Mol Cell</source>. <year>2011</year>;<volume>42</volume>:<fpage>511</fpage>-<lpage>23</lpage>.</citation>
</ref>
<ref id="bibr80-1947601912473477">
<label>80.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Glotzer</surname><given-names>M</given-names></name>
<name><surname>Murray</surname><given-names>AW</given-names></name>
<name><surname>Kirschner</surname><given-names>MW</given-names></name>
</person-group>. <article-title>Cyclin is degraded by the ubiquitin pathway</article-title>. <source>Nature</source>. <year>1991</year>;<volume>349</volume>:<fpage>132</fpage>-<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr81-1947601912473477">
<label>81.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pfleger</surname><given-names>CM</given-names></name>
<name><surname>Kirschner</surname><given-names>MW</given-names></name>
</person-group>. <article-title>The KEN box: an APC recognition signal distinct from the D box targeted by Cdh1</article-title>. <source>Genes Dev</source>. <year>2000</year>;<volume>14</volume>:<fpage>655</fpage>-<lpage>65</lpage>.</citation>
</ref>
<ref id="bibr82-1947601912473477">
<label>82.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lukas</surname><given-names>C</given-names></name>
<name><surname>Sorensen</surname><given-names>CS</given-names></name>
<name><surname>Kramer</surname><given-names>E</given-names></name>
<etal/></person-group>. <article-title>Accumulation of cyclin B1 requires E2F and cyclin-A-dependent rearrangement of the anaphase-promoting complex</article-title>. <source>Nature</source>. <year>1999</year>;<volume>401</volume>:<fpage>815</fpage>-<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr83-1947601912473477">
<label>83.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sowa</surname><given-names>ME</given-names></name>
<name><surname>Bennett</surname><given-names>EJ</given-names></name>
<name><surname>Gygi</surname><given-names>SP</given-names></name>
<name><surname>Harper</surname><given-names>JW</given-names></name>
</person-group>. <article-title>Defining the human deubiquitinating enzyme interaction landscape</article-title>. <source>Cell</source>. <year>2009</year>;<volume>138</volume>:<fpage>389</fpage>-<lpage>403</lpage>.</citation>
</ref>
<ref id="bibr84-1947601912473477">
<label>84.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Burrows</surname><given-names>AC</given-names></name>
<name><surname>Prokop</surname><given-names>J</given-names></name>
<name><surname>Summers</surname><given-names>MK</given-names></name>
</person-group>. <article-title>Skp1-Cul1-F-box ubiquitin ligase (SCFbetaTrCP)-mediated destruction of the ubiquitin-specific protease USP37 during G2-phase promotes mitotic entry</article-title>. <source>J Biol Chem</source>. <year>2012</year>;<volume>287</volume>:<fpage>39021</fpage>-<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr85-1947601912473477">
<label>85.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dikic</surname><given-names>I</given-names></name>
<name><surname>Wakatsuki</surname><given-names>S</given-names></name>
<name><surname>Walters</surname><given-names>KJ</given-names></name>
</person-group>. <article-title>Ubiquitin-binding domains—from structures to functions</article-title>. <source>Nat Rev Mol Cell Biol</source>. <year>2009</year>;<volume>10</volume>:<fpage>659</fpage>-<lpage>71</lpage>.</citation>
</ref>
<ref id="bibr86-1947601912473477">
<label>86.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Husnjak</surname><given-names>K</given-names></name>
<name><surname>Dikic</surname><given-names>I</given-names></name>
</person-group>. <article-title>Ubiquitin-binding proteins: decoders of ubiquitin-mediated cellular functions</article-title>. <source>Annu Rev Biochem</source>. <year>2012</year>;<volume>81</volume>:<fpage>291</fpage>-<lpage>322</lpage>.</citation>
</ref>
<ref id="bibr87-1947601912473477">
<label>87.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rahighi</surname><given-names>S</given-names></name>
<name><surname>Dikic</surname><given-names>I</given-names></name>
</person-group>. <article-title>Selectivity of the ubiquitin-binding modules</article-title>. <source>FEBS Lett</source>. <year>2012</year>;<volume>586</volume>:<fpage>2705</fpage>-<lpage>10</lpage>.</citation>
</ref>
<ref id="bibr88-1947601912473477">
<label>88.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hurley</surname><given-names>JH</given-names></name>
<name><surname>Lee</surname><given-names>S</given-names></name>
<name><surname>Prag</surname><given-names>G</given-names></name>
</person-group>. <article-title>Ubiquitin-binding domains</article-title>. <source>Biochem J</source>. <year>2006</year>;<volume>399</volume>:<fpage>361</fpage>-<lpage>72</lpage>.</citation>
</ref>
<ref id="bibr89-1947601912473477">
<label>89.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Biggins</surname><given-names>S</given-names></name>
<name><surname>Ivanovska</surname><given-names>I</given-names></name>
<name><surname>Rose</surname><given-names>MD</given-names></name>
</person-group>. <article-title>Yeast ubiquitin-like genes are involved in duplication of the microtubule organizing center</article-title>. <source>J Cell Biol</source>. <year>1996</year>;<volume>133</volume>:<fpage>1331</fpage>-<lpage>46</lpage>.</citation>
</ref>
<ref id="bibr90-1947601912473477">
<label>90.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Clarke</surname><given-names>DJ</given-names></name>
<name><surname>Mondesert</surname><given-names>G</given-names></name>
<name><surname>Segal</surname><given-names>M</given-names></name>
<etal/></person-group>. <article-title>Dosage suppressors of pds1 implicate ubiquitin-associated domains in checkpoint control</article-title>. <source>Mol Cell Biol</source>. <year>2001</year>;<volume>21</volume>:<fpage>1997</fpage>-<lpage>2007</lpage>.</citation>
</ref>
<ref id="bibr91-1947601912473477">
<label>91.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Verma</surname><given-names>R</given-names></name>
<name><surname>Oania</surname><given-names>R</given-names></name>
<name><surname>Graumann</surname><given-names>J</given-names></name>
<name><surname>Deshaies</surname><given-names>RJ</given-names></name>
</person-group>. <article-title>Multiubiquitin chain receptors define a layer of substrate selectivity in the ubiquitin-proteasome system</article-title>. <source>Cell</source>. <year>2004</year>;<volume>118</volume>:<fpage>99</fpage>-<lpage>110</lpage>.</citation>
</ref>
<ref id="bibr92-1947601912473477">
<label>92.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Elsasser</surname><given-names>S</given-names></name>
<name><surname>Chandler-Militello</surname><given-names>D</given-names></name>
<name><surname>Muller</surname><given-names>B</given-names></name>
<name><surname>Hanna</surname><given-names>J</given-names></name>
<name><surname>Finley</surname><given-names>D</given-names></name>
</person-group>. <article-title>Rad23 and Rpn10 serve as alternative ubiquitin receptors for the proteasome</article-title>. <source>J Biol Chem</source>. <year>2004</year>;<volume>279</volume>:<fpage>26817</fpage>-<lpage>22</lpage>.</citation>
</ref>
<ref id="bibr93-1947601912473477">
<label>93.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kang</surname><given-names>Y</given-names></name>
<name><surname>Vossler</surname><given-names>RA</given-names></name>
<name><surname>Diaz-Martinez</surname><given-names>LA</given-names></name>
<name><surname>Winter</surname><given-names>NS</given-names></name>
<name><surname>Clarke</surname><given-names>DJ</given-names></name>
<name><surname>Walters</surname><given-names>KJ</given-names></name>
</person-group>. <article-title>UBL/UBA ubiquitin receptor proteins bind a common tetraubiquitin chain</article-title>. <source>J Mol Biol</source>. <year>2006</year>;<volume>356</volume>:<fpage>1027</fpage>-<lpage>35</lpage>.</citation>
</ref>
<ref id="bibr94-1947601912473477">
<label>94.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dobrynin</surname><given-names>G</given-names></name>
<name><surname>Popp</surname><given-names>O</given-names></name>
<name><surname>Romer</surname><given-names>T</given-names></name>
<etal/></person-group>. <article-title>Cdc48/p97-Ufd1-Npl4 antagonizes Aurora B during chromosome segregation in HeLa cells</article-title>. <source>J Cell Sci</source>. <year>2011</year>;<volume>124</volume>:<fpage>1571</fpage>-<lpage>80</lpage>.</citation>
</ref>
<ref id="bibr95-1947601912473477">
<label>95.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cheng</surname><given-names>YL</given-names></name>
<name><surname>Chen</surname><given-names>RH</given-names></name>
</person-group>. <article-title>The AAA-ATPase Cdc48 and cofactor Shp1 promote chromosome bi-orientation by balancing Aurora B activity</article-title>. <source>J Cell Sci</source>. <year>2010</year>;<volume>123</volume>:<fpage>2025</fpage>-<lpage>34</lpage>.</citation>
</ref>
<ref id="bibr96-1947601912473477">
<label>96.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ramadan</surname><given-names>K</given-names></name>
<name><surname>Bruderer</surname><given-names>R</given-names></name>
<name><surname>Spiga</surname><given-names>FM</given-names></name>
<etal/></person-group>. <article-title>Cdc48/p97 promotes reformation of the nucleus by extracting the kinase Aurora B from chromatin</article-title>. <source>Nature</source>. <year>2007</year>;<volume>450</volume>:<fpage>1258</fpage>-<lpage>62</lpage>.</citation>
</ref>
<ref id="bibr97-1947601912473477">
<label>97.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chen</surname><given-names>L</given-names></name>
<name><surname>Shinde</surname><given-names>U</given-names></name>
<name><surname>Ortolan</surname><given-names>TG</given-names></name>
<name><surname>Madura</surname><given-names>K</given-names></name>
</person-group>. <article-title>Ubiquitin-associated (UBA) domains in Rad23 bind ubiquitin and promote inhibition of multi-ubiquitin chain assembly</article-title>. <source>EMBO Rep</source>. <year>2001</year>;<volume>2</volume>:<fpage>933</fpage>-<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr98-1947601912473477">
<label>98.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bertolaet</surname><given-names>BL</given-names></name>
<name><surname>Clarke</surname><given-names>DJ</given-names></name>
<name><surname>Wolff</surname><given-names>M</given-names></name>
<etal/></person-group>. <article-title>UBA domains of DNA damage-inducible proteins interact with ubiquitin</article-title>. <source>Nat Struct Biol</source>. <year>2001</year>;<volume>8</volume>:<fpage>417</fpage>-<lpage>22</lpage>.</citation>
</ref>
<ref id="bibr99-1947601912473477">
<label>99.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Funakoshi</surname><given-names>M</given-names></name>
<name><surname>Sasaki</surname><given-names>T</given-names></name>
<name><surname>Nishimoto</surname><given-names>T</given-names></name>
<name><surname>Kobayashi</surname><given-names>H</given-names></name>
</person-group>. <article-title>Budding yeast Dsk2p is a polyubiquitin-binding protein that can interact with the proteasome</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2002</year>; <volume>99</volume>:<fpage>745</fpage>-<lpage>50</lpage>.</citation>
</ref>
<ref id="bibr100-1947601912473477">
<label>100.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lambertson</surname><given-names>D</given-names></name>
<name><surname>Chen</surname><given-names>L</given-names></name>
<name><surname>Madura</surname><given-names>K</given-names></name>
</person-group>. <article-title>Investigating the importance of proteasome-interaction for Rad23 function</article-title>. <source>Curr Genet</source>. <year>2003</year>;<volume>42</volume>:<fpage>199</fpage>-<lpage>208</lpage>.</citation>
</ref>
<ref id="bibr101-1947601912473477">
<label>101.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Salah</surname><given-names>SM</given-names></name>
<name><surname>Nasmyth</surname><given-names>K</given-names></name>
</person-group>. <article-title>Destruction of the securin Pds1p occurs at the onset of anaphase during both meiotic divisions in yeast</article-title>. <source>Chromosoma</source>. <year>2000</year>;<volume>109</volume>:<fpage>27</fpage>-<lpage>34</lpage>.</citation>
</ref>
<ref id="bibr102-1947601912473477">
<label>102.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hilioti</surname><given-names>Z</given-names></name>
<name><surname>Chung</surname><given-names>YS</given-names></name>
<name><surname>Mochizuki</surname><given-names>Y</given-names></name>
<name><surname>Hardy</surname><given-names>CF</given-names></name>
<name><surname>Cohen-Fix</surname><given-names>O</given-names></name>
</person-group>. <article-title>The anaphase inhibitor Pds1 binds to the APC/C-associated protein Cdc20 in a destruction box-dependent manner</article-title>. <source>Curr Biol</source>. <year>2001</year>;<volume>11</volume>:<fpage>1347</fpage>-<lpage>52</lpage>.</citation>
</ref>
<ref id="bibr103-1947601912473477">
<label>103.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ciosk</surname><given-names>R</given-names></name>
<name><surname>Zachariae</surname><given-names>W</given-names></name>
<name><surname>Michaelis</surname><given-names>C</given-names></name>
<name><surname>Shevchenko</surname><given-names>A</given-names></name>
<name><surname>Mann</surname><given-names>M</given-names></name>
<name><surname>Nasmyth</surname><given-names>K</given-names></name>
</person-group>. <article-title>An ESP1/PDS1 complex regulates loss of sister chromatid cohesion at the metaphase to anaphase transition in yeast</article-title>. <source>Cell</source>. <year>1998</year>;<volume>93</volume>:<fpage>1067</fpage>-<lpage>76</lpage>.</citation>
</ref>
<ref id="bibr104-1947601912473477">
<label>104.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cohen-Fix</surname><given-names>O</given-names></name>
<name><surname>Peters</surname><given-names>JM</given-names></name>
<name><surname>Kirschner</surname><given-names>MW</given-names></name>
<name><surname>Koshland</surname><given-names>D</given-names></name>
</person-group>. <article-title>Anaphase initiation in Saccharomyces cerevisiae is controlled by the APC-dependent degradation of the anaphase inhibitor Pds1p</article-title>. <source>Genes Dev</source>. <year>1996</year>;<volume>10</volume>:<fpage>3081</fpage>-<lpage>93</lpage>.</citation>
</ref>
<ref id="bibr105-1947601912473477">
<label>105.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rao</surname><given-names>H</given-names></name>
<name><surname>Sastry</surname><given-names>A</given-names></name>
</person-group>. <article-title>Recognition of specific ubiquitin conjugates is important for the proteolytic functions of the ubiquitin-associated domain proteins Dsk2 and Rad23</article-title>. <source>J Biol Chem</source>. <year>2002</year>;<volume>277</volume>:<fpage>11691</fpage>-<lpage>5</lpage>.</citation>
</ref>
<ref id="bibr106-1947601912473477">
<label>106.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Diaz-Martinez</surname><given-names>LA</given-names></name>
<name><surname>Kang</surname><given-names>Y</given-names></name>
<name><surname>Walters</surname><given-names>KJ</given-names></name>
<name><surname>Clarke</surname><given-names>DJ</given-names></name>
</person-group>. <article-title>Yeast UBL-UBA proteins have partially redundant functions in cell cycle control</article-title>. <source>Cell Div</source>. <year>2006</year>;<volume>1</volume>:<fpage>28</fpage>.</citation>
</ref>
<ref id="bibr107-1947601912473477">
<label>107.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bertolaet</surname><given-names>BL</given-names></name>
<name><surname>Clarke</surname><given-names>DJ</given-names></name>
<name><surname>Wolff</surname><given-names>M</given-names></name>
<etal/></person-group>. <article-title>UBA domains mediate protein-protein interactions between two DNA damage-inducible proteins</article-title>. <source>J Mol Biol</source>. <year>2001</year>;<volume>313</volume>:<fpage>955</fpage>-<lpage>63</lpage>.</citation>
</ref>
<ref id="bibr108-1947601912473477">
<label>108.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gabriely</surname><given-names>G</given-names></name>
<name><surname>Kama</surname><given-names>R</given-names></name>
<name><surname>Gelin-Licht</surname><given-names>R</given-names></name>
<name><surname>Gerst</surname><given-names>JE</given-names></name>
</person-group>. <article-title>Different domains of the UBL-UBA ubiquitin receptor, Ddi1/Vsm1, are involved in its multiple cellular roles</article-title>. <source>Mol Biol Cell</source>. <year>2008</year>;<volume>19</volume>:<fpage>3625</fpage>-<lpage>37</lpage>.</citation>
</ref>
<ref id="bibr109-1947601912473477">
<label>109.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Deveraux</surname><given-names>Q</given-names></name>
<name><surname>Ustrell</surname><given-names>V</given-names></name>
<name><surname>Pickart</surname><given-names>C</given-names></name>
<name><surname>Rechsteiner</surname><given-names>M</given-names></name>
</person-group>. <article-title>A 26 S protease subunit that binds ubiquitin conjugates</article-title>. <source>J Biol Chem</source>. <year>1994</year>;<volume>269</volume>:<fpage>7059</fpage>-<lpage>61</lpage>.</citation>
</ref>
<ref id="bibr110-1947601912473477">
<label>110.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mayor</surname><given-names>T</given-names></name>
<name><surname>Lipford</surname><given-names>JR</given-names></name>
<name><surname>Graumann</surname><given-names>J</given-names></name>
<name><surname>Smith</surname><given-names>GT</given-names></name>
<name><surname>Deshaies</surname><given-names>RJ</given-names></name>
</person-group>. <article-title>Analysis of polyubiquitin conjugates reveals that the Rpn10 substrate receptor contributes to the turnover of multiple proteasome targets</article-title>. <source>Mol Cell Proteomics</source>. <year>2005</year>;<volume>4</volume>: <fpage>741</fpage>-<lpage>51</lpage>.</citation>
</ref>
<ref id="bibr111-1947601912473477">
<label>111.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Barberis</surname><given-names>M</given-names></name>
<name><surname>Linke</surname><given-names>C</given-names></name>
<name><surname>Adrover</surname><given-names>MA</given-names></name>
<etal/></person-group>. <article-title>Sic1 plays a role in timing and oscillatory behaviour of B-type cyclins</article-title>. <source>Biotechnol Adv</source>. <year>2012</year>;<volume>30</volume>:<fpage>108</fpage>-<lpage>30</lpage>.</citation>
</ref>
<ref id="bibr112-1947601912473477">
<label>112.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chee</surname><given-names>MK</given-names></name>
<name><surname>Haase</surname><given-names>SB</given-names></name>
</person-group>. <article-title>B-cyclin/CDKs regulate mitotic spindle assembly by phosphorylating kinesins-5 in budding yeast</article-title>. <source>PLoS Genet</source>. <year>2010</year>;<volume>6</volume>:<fpage>e1000935</fpage>.</citation>
</ref>
<ref id="bibr113-1947601912473477">
<label>113.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Verma</surname><given-names>R</given-names></name>
<name><surname>Annan</surname><given-names>RS</given-names></name>
<name><surname>Huddleston</surname><given-names>MJ</given-names></name>
<name><surname>Carr</surname><given-names>SA</given-names></name>
<name><surname>Reynard</surname><given-names>G</given-names></name>
<name><surname>Deshaies</surname><given-names>RJ</given-names></name>
</person-group>. <article-title>Phosphorylation of Sic1p by G1 Cdk required for its degradation and entry into S phase</article-title>. <source>Science</source>. <year>1997</year>;<volume>278</volume>:<fpage>455</fpage>-<lpage>60</lpage>.</citation>
</ref>
<ref id="bibr114-1947601912473477">
<label>114.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lengronne</surname><given-names>A</given-names></name>
<name><surname>Schwob</surname><given-names>E</given-names></name>
</person-group>. <article-title>The yeast CDK inhibitor Sic1 prevents genomic instability by promoting replication origin licensing in late G(1)</article-title>. <source>Mol Cell</source>. <year>2002</year>;<volume>9</volume>:<fpage>1067</fpage>-<lpage>78</lpage>.</citation>
</ref>
<ref id="bibr115-1947601912473477">
<label>115.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Calzada</surname><given-names>A</given-names></name>
<name><surname>Sacristan</surname><given-names>M</given-names></name>
<name><surname>Sanchez</surname><given-names>E</given-names></name>
<name><surname>Bueno</surname><given-names>A</given-names></name>
</person-group>. <article-title>Cdc6 cooperates with Sic1 and Hct1 to inactivate mitotic cyclin-dependent kinases</article-title>. <source>Nature</source>. <year>2001</year>;<volume>412</volume>:<fpage>355</fpage>-<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr116-1947601912473477">
<label>116.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Donovan</surname><given-names>JD</given-names></name>
<name><surname>Toyn</surname><given-names>JH</given-names></name>
<name><surname>Johnson</surname><given-names>AL</given-names></name>
<name><surname>Johnston</surname><given-names>LH</given-names></name>
</person-group>. <article-title>P40SDB25, a putative CDK inhibitor, has a role in the M/G1 transition in Saccharomyces cerevisiae</article-title>. <source>Genes Dev</source>. <year>1994</year>;<volume>8</volume>:<fpage>1640</fpage>-<lpage>53</lpage>.</citation>
</ref>
<ref id="bibr117-1947601912473477">
<label>117.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tripodi</surname><given-names>F</given-names></name>
<name><surname>Zinzalla</surname><given-names>V</given-names></name>
<name><surname>Vanoni</surname><given-names>M</given-names></name>
<name><surname>Alberghina</surname><given-names>L</given-names></name>
<name><surname>Coccetti</surname><given-names>P</given-names></name>
</person-group>. <article-title>In CK2 inactivated cells the cyclin dependent kinase inhibitor Sic1 is involved in cell-cycle arrest before the onset of S phase</article-title>. <source>Biochem Biophys Res Commun</source>. <year>2007</year>;<volume>359</volume>:<fpage>921</fpage>-<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr118-1947601912473477">
<label>118.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Szlanka</surname><given-names>T</given-names></name>
<name><surname>Haracska</surname><given-names>L</given-names></name>
<name><surname>Kiss</surname><given-names>I</given-names></name>
<etal/></person-group>. <article-title>Deletion of proteasomal subunit S5a/Rpn10/p54 causes lethality, multiple mitotic defects and overexpression of proteasomal genes in Drosophila melanogaster</article-title>. <source>J Cell Sci</source>. <year>2003</year>;<volume>116</volume>:<fpage>1023</fpage>-<lpage>33</lpage>.</citation>
</ref>
<ref id="bibr119-1947601912473477">
<label>119.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Li</surname><given-names>Z</given-names></name>
<name><surname>Wang</surname><given-names>CC</given-names></name>
</person-group>. <article-title>Functional characterization of the 11 non-ATPase subunit proteins in the trypanosome 19 S proteasomal regulatory complex</article-title>. <source>J Biol Chem</source>. <year>2002</year>;<volume>277</volume>:<fpage>42686</fpage>-<lpage>93</lpage>.</citation>
</ref>
<ref id="bibr120-1947601912473477">
<label>120.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ye</surname><given-names>Y</given-names></name>
</person-group>. <article-title>Diverse functions with a common regulator: ubiquitin takes command of an AAA ATPase</article-title>. <source>J Struct Biol</source>. <year>2006</year>;<volume>156</volume>:<fpage>29</fpage>-<lpage>40</lpage>.</citation>
</ref>
<ref id="bibr121-1947601912473477">
<label>121.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kondo</surname><given-names>H</given-names></name>
<name><surname>Rabouille</surname><given-names>C</given-names></name>
<name><surname>Newman</surname><given-names>R</given-names></name>
<etal/></person-group>. <article-title>p47 is a cofactor for p97-mediated membrane fusion</article-title>. <source>Nature</source>. <year>1997</year>;<volume>388</volume>:<fpage>75</fpage>-<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr122-1947601912473477">
<label>122.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Meyer</surname><given-names>HH</given-names></name>
<name><surname>Shorter</surname><given-names>JG</given-names></name>
<name><surname>Seemann</surname><given-names>J</given-names></name>
<name><surname>Pappin</surname><given-names>D</given-names></name>
<name><surname>Warren</surname><given-names>G</given-names></name>
</person-group>. <article-title>A complex of mammalian ufd1 and npl4 links the AAA-ATPase, p97, to ubiquitin and nuclear transport pathways</article-title>. <source>EMBO J</source>. <year>2000</year>;<volume>19</volume>:<fpage>2181</fpage>-<lpage>92</lpage>.</citation>
</ref>
<ref id="bibr123-1947601912473477">
<label>123.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schuberth</surname><given-names>C</given-names></name>
<name><surname>Buchberger</surname><given-names>A</given-names></name>
</person-group>. <article-title>UBX domain proteins: major regulators of the AAA ATPase Cdc48/p97</article-title>. <source>Cell Mol Life Sci</source>. <year>2008</year>;<volume>65</volume>:<fpage>2360</fpage>-<lpage>71</lpage>.</citation>
</ref>
<ref id="bibr124-1947601912473477">
<label>124.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lindon</surname><given-names>C</given-names></name>
<name><surname>Pines</surname><given-names>J</given-names></name>
</person-group>. <article-title>Ordered proteolysis in anaphase inactivates Plk1 to contribute to proper mitotic exit in human cells</article-title>. <source>J Cell Biol</source>. <year>2004</year>;<volume>164</volume>:<fpage>233</fpage>-<lpage>41</lpage>.</citation>
</ref>
<ref id="bibr125-1947601912473477">
<label>125.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vong</surname><given-names>QP</given-names></name>
<name><surname>Cao</surname><given-names>K</given-names></name>
<name><surname>Li</surname><given-names>HY</given-names></name>
<name><surname>Iglesias</surname><given-names>PA</given-names></name>
<name><surname>Zheng</surname><given-names>Y</given-names></name>
</person-group>. <article-title>Chromosome alignment and segregation regulated by ubiquitination of survivin</article-title>. <source>Science</source>. <year>2005</year>;<volume>310</volume>:<fpage>1499</fpage>-<lpage>504</lpage>.</citation>
</ref>
<ref id="bibr126-1947601912473477">
<label>126.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Al-Hakim</surname><given-names>AK</given-names></name>
<name><surname>Zagorska</surname><given-names>A</given-names></name>
<name><surname>Chapman</surname><given-names>L</given-names></name>
<name><surname>Deak</surname><given-names>M</given-names></name>
<name><surname>Peggie</surname><given-names>M</given-names></name>
<name><surname>Alessi</surname><given-names>DR</given-names></name>
</person-group>. <article-title>Control of AMPK-related kinases by USP9X and atypical Lys(29)/Lys(33)-linked polyubiquitin chains</article-title>. <source>Biochem J</source>. <year>2008</year>;<volume>411</volume>:<fpage>249</fpage>-<lpage>60</lpage>.</citation>
</ref>
<ref id="bibr127-1947601912473477">
<label>127.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Heallen</surname><given-names>TR</given-names></name>
<name><surname>Adams</surname><given-names>HP</given-names></name>
<name><surname>Furuta</surname><given-names>T</given-names></name>
<name><surname>Verbrugghe</surname><given-names>KJ</given-names></name>
<name><surname>Schumacher</surname><given-names>JM</given-names></name>
</person-group>. <article-title>An Afg2/Spaf-related Cdc48-like AAA ATPase regulates the stability and activity of the C. elegans Aurora B kinase AIR-2</article-title>. <source>Dev Cell</source>. <year>2008</year>;<volume>15</volume>:<fpage>603</fpage>-<lpage>16</lpage>.</citation>
</ref>
<ref id="bibr128-1947601912473477">
<label>128.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mouysset</surname><given-names>J</given-names></name>
<name><surname>Deichsel</surname><given-names>A</given-names></name>
<name><surname>Moser</surname><given-names>S</given-names></name>
<etal/></person-group>. <article-title>Cell cycle progression requires the CDC-48UFD-1/NPL-4 complex for efficient DNA replication</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2008</year>;<volume>105</volume>:<fpage>12879</fpage>-<lpage>84</lpage>.</citation>
</ref>
<ref id="bibr129-1947601912473477">
<label>129.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chen</surname><given-names>M</given-names></name>
<name><surname>Gutierrez</surname><given-names>GJ</given-names></name>
<name><surname>Ronai</surname><given-names>ZA</given-names></name>
</person-group>. <article-title>Ubiquitin-recognition protein Ufd1 couples the endoplasmic reticulum (ER) stress response to cell cycle control</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2011</year>;<volume>108</volume>:<fpage>9119</fpage>-<lpage>24</lpage>.</citation>
</ref>
<ref id="bibr130-1947601912473477">
<label>130.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Eletr</surname><given-names>ZM</given-names></name>
<name><surname>Wilkinson</surname><given-names>KD</given-names></name>
</person-group>. <article-title>An emerging model for BAP1’s role in regulating cell cycle progression</article-title>. <source>Cell Biochem Biophys</source>. <year>2011</year>;<volume>60</volume>:<fpage>3</fpage>-<lpage>11</lpage>.</citation>
</ref>
<ref id="bibr131-1947601912473477">
<label>131.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nijman</surname><given-names>SM</given-names></name>
<name><surname>Huang</surname><given-names>TT</given-names></name>
<name><surname>Dirac</surname><given-names>AM</given-names></name>
<etal/></person-group>. <article-title>The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway</article-title>. <source>Mol Cell</source>. <year>2005</year>;<volume>17</volume>:<fpage>331</fpage>-<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr132-1947601912473477">
<label>132.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Oestergaard</surname><given-names>VH</given-names></name>
<name><surname>Langevin</surname><given-names>F</given-names></name>
<name><surname>Kuiken</surname><given-names>HJ</given-names></name>
<etal/></person-group>. <article-title>Deubiquitination of FANCD2 is required for DNA crosslink repair</article-title>. <source>Mol Cell</source>. <year>2007</year>;<volume>28</volume>:<fpage>798</fpage>-<lpage>809</lpage>.</citation>
</ref>
<ref id="bibr133-1947601912473477">
<label>133.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Smogorzewska</surname><given-names>A</given-names></name>
<name><surname>Matsuoka</surname><given-names>S</given-names></name>
<name><surname>Vinciguerra</surname><given-names>P</given-names></name>
<etal/></person-group>. <article-title>Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair</article-title>. <source>Cell</source>. <year>2007</year>;<volume>129</volume>:<fpage>289</fpage>-<lpage>301</lpage>.</citation>
</ref>
<ref id="bibr134-1947601912473477">
<label>134.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Huang</surname><given-names>TT</given-names></name>
<name><surname>Nijman</surname><given-names>SM</given-names></name>
<name><surname>Mirchandani</surname><given-names>KD</given-names></name>
<etal/></person-group>. <article-title>Regulation of monoubiquitinated PCNA by DUB autocleavage</article-title>. <source>Nat Cell Biol</source>. <year>2006</year>;<volume>8</volume>:<fpage>339</fpage>-<lpage>47</lpage>.</citation>
</ref>
<ref id="bibr135-1947601912473477">
<label>135.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nicassio</surname><given-names>F</given-names></name>
<name><surname>Corrado</surname><given-names>N</given-names></name>
<name><surname>Vissers</surname><given-names>JH</given-names></name>
<etal/></person-group>. <article-title>Human USP3 is a chromatin modifier required for S phase progression and genome stability</article-title>. <source>Curr Biol</source>. <year>2007</year>;<volume>17</volume>:<fpage>1972</fpage>-<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr136-1947601912473477">
<label>136.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sobhian</surname><given-names>B</given-names></name>
<name><surname>Shao</surname><given-names>G</given-names></name>
<name><surname>Lilli</surname><given-names>DR</given-names></name>
<etal/></person-group>. <article-title>RAP80 targets BRCA1 to specific ubiquitin structures at DNA damage sites</article-title>. <source>Science</source>. <year>2007</year>;<volume>316</volume>:<fpage>1198</fpage>-<lpage>202</lpage>.</citation>
</ref>
<ref id="bibr137-1947601912473477">
<label>137.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Shao</surname><given-names>G</given-names></name>
<name><surname>Lilli</surname><given-names>DR</given-names></name>
<name><surname>Patterson-Fortin</surname><given-names>J</given-names></name>
<name><surname>Coleman</surname><given-names>KA</given-names></name>
<name><surname>Morrissey</surname><given-names>DE</given-names></name>
<name><surname>Greenberg</surname><given-names>RA</given-names></name>
</person-group>. <article-title>The Rap80-BRCC36 de-ubiquitinating enzyme complex antagonizes RNF8-Ubc13-dependent ubiquitination events at DNA double strand breaks</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2009</year>;<volume>106</volume>:<fpage>3166</fpage>-<lpage>71</lpage>.</citation>
</ref>
<ref id="bibr138-1947601912473477">
<label>138.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sato</surname><given-names>Y</given-names></name>
<name><surname>Yamagata</surname><given-names>A</given-names></name>
<name><surname>Goto-Ito</surname><given-names>S</given-names></name>
<etal/></person-group>. <article-title>Molecular basis of Lys-63-linked polyubiquitination inhibition by the interaction between human deubiquitinating enzyme OTUB1 and ubiquitin-conjugating enzyme UBC13</article-title>. <source>J Biol Chem</source>. <year>2012</year>;<volume>287</volume>:<fpage>25860</fpage>-<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr139-1947601912473477">
<label>139.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>D</given-names></name>
<name><surname>Zaugg</surname><given-names>K</given-names></name>
<name><surname>Mak</surname><given-names>TW</given-names></name>
<name><surname>Elledge</surname><given-names>SJ</given-names></name>
</person-group>. <article-title>A role for the deubiquitinating enzyme USP28 in control of the DNA-damage response</article-title>. <source>Cell</source>. <year>2006</year>;<volume>126</volume>:<fpage>529</fpage>-<lpage>42</lpage>.</citation>
</ref>
<ref id="bibr140-1947601912473477">
<label>140.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Popov</surname><given-names>N</given-names></name>
<name><surname>Wanzel</surname><given-names>M</given-names></name>
<name><surname>Madiredjo</surname><given-names>M</given-names></name>
<etal/></person-group>. <article-title>The ubiquitin-specific protease USP28 is required for MYC stability</article-title>. <source>Nat Cell Biol</source>. <year>2007</year>;<volume>9</volume>:<fpage>765</fpage>-<lpage>74</lpage>.</citation>
</ref>
<ref id="bibr141-1947601912473477">
<label>141.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Li</surname><given-names>M</given-names></name>
<name><surname>Brooks</surname><given-names>CL</given-names></name>
<name><surname>Kon</surname><given-names>N</given-names></name>
<name><surname>Gu</surname><given-names>W</given-names></name>
</person-group>. <article-title>A dynamic role of HAUSP in the p53-Mdm2 pathway</article-title>. <source>Mol Cell</source>. <year>2004</year>;<volume>13</volume>:<fpage>879</fpage>-<lpage>86</lpage>.</citation>
</ref>
<ref id="bibr142-1947601912473477">
<label>142.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Li</surname><given-names>M</given-names></name>
<name><surname>Chen</surname><given-names>D</given-names></name>
<name><surname>Shiloh</surname><given-names>A</given-names></name>
<etal/></person-group>. <article-title>Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization</article-title>. <source>Nature</source>. <year>2002</year>;<volume>416</volume>:<fpage>648</fpage>-<lpage>53</lpage>.</citation>
</ref>
<ref id="bibr143-1947601912473477">
<label>143.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hock</surname><given-names>AK</given-names></name>
<name><surname>Vigneron</surname><given-names>AM</given-names></name>
<name><surname>Carter</surname><given-names>S</given-names></name>
<name><surname>Ludwig</surname><given-names>RL</given-names></name>
<name><surname>Vousden</surname><given-names>KH</given-names></name>
</person-group>. <article-title>Regulation of p53 stability and function by the deubiquitinating enzyme USP42</article-title>. <source>EMBO J</source>. <year>2011</year>;<volume>30</volume>:<fpage>4921</fpage>-<lpage>30</lpage>.</citation>
</ref>
<ref id="bibr144-1947601912473477">
<label>144.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stevenson</surname><given-names>LF</given-names></name>
<name><surname>Sparks</surname><given-names>A</given-names></name>
<name><surname>Allende-Vega</surname><given-names>N</given-names></name>
<name><surname>Xirodimas</surname><given-names>DP</given-names></name>
<name><surname>Lane</surname><given-names>DP</given-names></name>
<name><surname>Saville</surname><given-names>MK</given-names></name>
</person-group>. <article-title>The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2</article-title>. <source>EMBO J</source>. <year>2007</year>;<volume>26</volume>:<fpage>976</fpage>-<lpage>86</lpage>.</citation>
</ref>
<ref id="bibr145-1947601912473477">
<label>145.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Aressy</surname><given-names>B</given-names></name>
<name><surname>Jullien</surname><given-names>D</given-names></name>
<name><surname>Cazales</surname><given-names>M</given-names></name>
<etal/></person-group>. <article-title>A screen for deubiquitinating enzymes involved in the G(2)/M checkpoint identifies USP50 as a regulator of HSP90-dependent Wee1 stability</article-title>. <source>Cell Cycle</source>. <year>2010</year>;<volume>9</volume>:<fpage>3815</fpage>-<lpage>22</lpage>.</citation>
</ref>
<ref id="bibr146-1947601912473477">
<label>146.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Joo</surname><given-names>HY</given-names></name>
<name><surname>Zhai</surname><given-names>L</given-names></name>
<name><surname>Yang</surname><given-names>C</given-names></name>
<etal/></person-group>. <article-title>Regulation of cell cycle progression and gene expression by H2A deubiquitination</article-title>. <source>Nature</source>. <year>2007</year>;<volume>449</volume>:<fpage>1068</fpage>-<lpage>72</lpage>.</citation>
</ref>
<ref id="bibr147-1947601912473477">
<label>147.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Shanbhag</surname><given-names>NM</given-names></name>
<name><surname>Rafalska-Metcalf</surname><given-names>IU</given-names></name>
<name><surname>Balane-Bolivar</surname><given-names>C</given-names></name>
<name><surname>Janicki</surname><given-names>SM</given-names></name>
<name><surname>Greenberg</surname><given-names>RA</given-names></name>
</person-group>. <article-title>ATM-dependent chromatin changes silence transcription in cis to DNA double-strand breaks</article-title>. <source>Cell</source>. <year>2010</year>;<volume>141</volume>:<fpage>970</fpage>-<lpage>81</lpage>.</citation>
</ref>
<ref id="bibr148-1947601912473477">
<label>148.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mukai</surname><given-names>A</given-names></name>
<name><surname>Mizuno</surname><given-names>E</given-names></name>
<name><surname>Kobayashi</surname><given-names>K</given-names></name>
<etal/></person-group>. <article-title>Dynamic regulation of ubiquitylation and deubiquitylation at the central spindle during cytokinesis</article-title>. <source>J Cell Sci</source>. <year>2008</year>;<volume>121</volume>:<fpage>1325</fpage>-<lpage>33</lpage>.</citation>
</ref>
<ref id="bibr149-1947601912473477">
<label>149.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kamura</surname><given-names>T</given-names></name>
<name><surname>Hara</surname><given-names>T</given-names></name>
<name><surname>Matsumoto</surname><given-names>M</given-names></name>
<etal/></person-group>. <article-title>Cytoplasmic ubiquitin ligase KPC regulates proteolysis of p27(Kip1) at G1 phase</article-title>. <source>Nat Cell Biol</source>. <year>2004</year>;<volume>6</volume>:<fpage>1229</fpage>-<lpage>35</lpage>.</citation>
</ref>
<ref id="bibr150-1947601912473477">
<label>150.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hara</surname><given-names>T</given-names></name>
<name><surname>Kamura</surname><given-names>T</given-names></name>
<name><surname>Kotoshiba</surname><given-names>S</given-names></name>
<etal/></person-group>. <article-title>Role of the UBL-UBA protein KPC2 in degradation of p27 at G1 phase of the cell cycle</article-title>. <source>Mol Cell Biol</source>. <year>2005</year>;<volume>25</volume>:<fpage>9292</fpage>-<lpage>303</lpage>.</citation>
</ref>
<ref id="bibr151-1947601912473477">
<label>151.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bienko</surname><given-names>M</given-names></name>
<name><surname>Green</surname><given-names>CM</given-names></name>
<name><surname>Crosetto</surname><given-names>N</given-names></name>
<etal/></person-group>. <article-title>Ubiquitin-binding domains in Y-family polymerases regulate translesion synthesis</article-title>. <source>Science</source>. <year>2005</year>;<volume>310</volume>:<fpage>1821</fpage>-<lpage>4</lpage>.</citation>
</ref>
<ref id="bibr152-1947601912473477">
<label>152.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bienko</surname><given-names>M</given-names></name>
<name><surname>Green</surname><given-names>CM</given-names></name>
<name><surname>Sabbioneda</surname><given-names>S</given-names></name>
<etal/></person-group>. <article-title>Regulation of translesion synthesis DNA polymerase eta by monoubiquitination</article-title>. <source>Mol Cell</source>. <year>2010</year>;<volume>37</volume>:<fpage>396</fpage>-<lpage>407</lpage>.</citation>
</ref>
<ref id="bibr153-1947601912473477">
<label>153.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Guo</surname><given-names>C</given-names></name>
<name><surname>Tang</surname><given-names>TS</given-names></name>
<name><surname>Bienko</surname><given-names>M</given-names></name>
<name><surname>Dikic</surname><given-names>I</given-names></name>
<name><surname>Friedberg</surname><given-names>EC</given-names></name>
</person-group>. <article-title>Requirements for the interaction of mouse Polkappa with ubiquitin and its biological significance</article-title>. <source>J Biol Chem</source>. <year>2008</year>;<volume>283</volume>: <fpage>4658</fpage>-<lpage>64</lpage>.</citation>
</ref>
<ref id="bibr154-1947601912473477">
<label>154.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Williams</surname><given-names>HL</given-names></name>
<name><surname>Gottesman</surname><given-names>ME</given-names></name>
<name><surname>Gautier</surname><given-names>J</given-names></name>
</person-group>. <article-title>Replication-independent repair of DNA interstrand crosslinks</article-title>. <source>Mol Cell</source>. <year>2012</year>;<volume>47</volume>:<fpage>140</fpage>-<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr155-1947601912473477">
<label>155.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Plosky</surname><given-names>BS</given-names></name>
<name><surname>Vidal</surname><given-names>AE</given-names></name>
<name><surname>Fernandez</surname><given-names>de</given-names></name>
<name><surname>Henestrosa</surname><given-names>AR</given-names></name>
<etal/></person-group>. <article-title>Controlling the subcellular localization of DNA polymerases iota and eta via interactions with ubiquitin</article-title>. <source>EMBO J</source>. <year>2006</year>;<volume>25</volume>:<fpage>2847</fpage>-<lpage>55</lpage>.</citation>
</ref>
<ref id="bibr156-1947601912473477">
<label>156.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bomar</surname><given-names>MG</given-names></name>
<name><surname>D’Souza</surname><given-names>S</given-names></name>
<name><surname>Bienko</surname><given-names>M</given-names></name>
<name><surname>Dikic</surname><given-names>I</given-names></name>
<name><surname>Walker</surname><given-names>GC</given-names></name>
<name><surname>Zhou</surname><given-names>P</given-names></name>
</person-group>. <article-title>Unconventional ubiquitin recognition by the ubiquitin-binding motif within the Y family DNA polymerases iota and Rev1</article-title>. <source>Mol Cell</source>. <year>2010</year>;<volume>37</volume>:<fpage>408</fpage>-<lpage>17</lpage>.</citation>
</ref>
<ref id="bibr157-1947601912473477">
<label>157.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Liu</surname><given-names>C</given-names></name>
<name><surname>van Dyk</surname><given-names>D</given-names></name>
<name><surname>Li</surname><given-names>Y</given-names></name>
<name><surname>Andrews</surname><given-names>B</given-names></name>
<name><surname>Rao</surname><given-names>H</given-names></name>
</person-group>. <article-title>A genome-wide synthetic dosage lethality screen reveals multiple pathways that require the functioning of ubiquitin-binding proteins Rad23 and Dsk2</article-title>. <source>BMC Biol</source>. <year>2009</year>;<volume>7</volume>:<fpage>75</fpage>.</citation>
</ref>
<ref id="bibr158-1947601912473477">
<label>158.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>H</given-names></name>
<name><surname>Chen</surname><given-names>J</given-names></name>
<name><surname>Yu</surname><given-names>X</given-names></name>
</person-group>. <article-title>Ubiquitin-binding protein RAP80 mediates BRCA1-dependent DNA damage response</article-title>. <source>Science</source>. <year>2007</year>;<volume>316</volume>:<fpage>1202</fpage>-<lpage>5</lpage>.</citation>
</ref>
<ref id="bibr159-1947601912473477">
<label>159.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yan</surname><given-names>J</given-names></name>
<name><surname>Kim</surname><given-names>YS</given-names></name>
<name><surname>Yang</surname><given-names>XP</given-names></name>
<etal/></person-group>. <article-title>The ubiquitin-interacting motif containing protein RAP80 interacts with BRCA1 and functions in DNA damage repair response</article-title>. <source>Cancer Res</source>. <year>2007</year>;<volume>67</volume>:<fpage>6647</fpage>-<lpage>56</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>